13.07.2015 Views

Regional Action Plan for Malaria Control and Elimination in the ...

Regional Action Plan for Malaria Control and Elimination in the ...

Regional Action Plan for Malaria Control and Elimination in the ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificWHO Library Catalogu<strong>in</strong>g <strong>in</strong> Publication Data<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific: (2010 - 2015).1. <strong>Malaria</strong> – prevention <strong>and</strong> control. 2. <strong>Malaria</strong> – epidemiology. 3. <strong>Regional</strong> health plann<strong>in</strong>g.4. Western Pacific.ISBN 978 92 9061 557 6 (NLM Classification: WC 765)© World Health Organization 2012All rights reserved. Publications of <strong>the</strong> World Health Organization can be obta<strong>in</strong>ed from WHO Press,World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerl<strong>and</strong> (tel.: +41 22 791 3264;fax: +41 22 791 4857; e-mail: bookorders@who.<strong>in</strong>t). Requests <strong>for</strong> permission to reproduce or translateWHO publications – whe<strong>the</strong>r <strong>for</strong> sale or <strong>for</strong> noncommercial distribution – should be addressed to WHOPress, at <strong>the</strong> above address (fax: +41 22 791 4806; e-mail: permissions@who.<strong>in</strong>t). For WHO WesternPacific <strong>Regional</strong> Publications, request <strong>for</strong> permission to reproduce should be addressed to <strong>the</strong> PublicationsOffice, World Health Organization, <strong>Regional</strong> Office <strong>for</strong> <strong>the</strong> Western Pacific, P.O. Box 2932, 1000, Manila,Philipp<strong>in</strong>es, (fax: +632 521 1036, e-mail: publications@wpro.who.<strong>in</strong>t).The designations employed <strong>and</strong> <strong>the</strong> presentation of <strong>the</strong> material <strong>in</strong> this publication do not imply <strong>the</strong>expression of any op<strong>in</strong>ion whatsoever on <strong>the</strong> part of <strong>the</strong> World Health Organization concern<strong>in</strong>g <strong>the</strong> legalstatus of any country, territory, city or area or of its authorities, or concern<strong>in</strong>g <strong>the</strong> delimitation of its frontiersor boundaries. Dotted l<strong>in</strong>es on maps represent approximate border l<strong>in</strong>es <strong>for</strong> which <strong>the</strong>re may not yet be fullagreement.The mention of specific companies or of certa<strong>in</strong> manufacturers’ products does not imply that <strong>the</strong>y areendorsed or recommended by <strong>the</strong> World Health Organization <strong>in</strong> preference to o<strong>the</strong>rs of a similar nature thatare not mentioned. Errors <strong>and</strong> omissions excepted, <strong>the</strong> names of proprietary products are dist<strong>in</strong>guished by<strong>in</strong>itial capital letters.All reasonable precautions have been taken by <strong>the</strong> World Health Organization to verify <strong>the</strong> <strong>in</strong><strong>for</strong>mationconta<strong>in</strong>ed <strong>in</strong> this publication. However, <strong>the</strong> published material is be<strong>in</strong>g distributed without warranty of anyk<strong>in</strong>d, ei<strong>the</strong>r expressed or implied. The responsibility <strong>for</strong> <strong>the</strong> <strong>in</strong>terpretation <strong>and</strong> use of <strong>the</strong> material lies with<strong>the</strong> reader. In no event shall <strong>the</strong> World Health Organization be liable <strong>for</strong> damages aris<strong>in</strong>g from its use.


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificTable of ContentsAcknowledgements.........................................................................................................................4Preface.............................................................................................................................................5<strong>Regional</strong> Committee Resolution WPR/RC60.R5, 2009.................................................................6Summary..........................................................................................................................................8<strong>Malaria</strong> situation <strong>in</strong> <strong>the</strong> Western Pacific Region.........................................................................12Key challenges <strong>and</strong> opportunities...............................................................................................15Development of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>..................................................................................24Role of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>.................................................................................................26Goal, Objectives <strong>and</strong> Targets of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>....................................................... 28<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong><strong>in</strong> <strong>the</strong> Western Pacific (2010 – 2015) Logical Framework...........................................................32


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificAbbreviationsACT<strong>Malaria</strong>APMENAusAIDG6PDGFGMAPGMIHIV/AIDSThe Asian Collaborative Tra<strong>in</strong><strong>in</strong>g Network <strong>for</strong> <strong>Malaria</strong>Asia-Pacific <strong>Malaria</strong> <strong>Elim<strong>in</strong>ation</strong> NetworkThe Australian Agency <strong>for</strong> International DevelopmentGlucose 6 Phosphate DehydrogenaseThe Global Fund to Fight AIDS, Tuberculosis <strong>and</strong> <strong>Malaria</strong>Global <strong>Malaria</strong> <strong>Action</strong> <strong>Plan</strong>Global <strong>Malaria</strong> IndicatorHuman Immunodeficiency Virus/Acquired ImmuneDeficiency SyndromeInterpolITNLLINM&EMCMDGsMEASUREMMPMVPRAPRBMRITMInternational Crim<strong>in</strong>al Police OrganizationInsecticide Treated NetsLong Last<strong>in</strong>g Insecticidal NetsMonitor<strong>in</strong>g <strong>and</strong> Evaluation<strong>Malaria</strong> ConsortiumMillennium Development GoalsMeasure/EVALUATIONMekong <strong>Malaria</strong> Programme<strong>Malaria</strong>, o<strong>the</strong>r Vectorborne <strong>and</strong> Parasitic Diseases<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>The Roll Back <strong>Malaria</strong> PartnershipThe Research Institute <strong>for</strong> Tropical Medic<strong>in</strong>e of <strong>the</strong> Philipp<strong>in</strong>es2


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificAbbreviationsSPCTDRThe Secretariat of <strong>the</strong> Pacific CommunityUNICEF/UNDP/World Bank/WHO Special Programme <strong>for</strong> Research<strong>and</strong> Tra<strong>in</strong><strong>in</strong>g <strong>in</strong> Tropical DiseasesUQUS CDCThe University of Queensl<strong>and</strong>, AustraliaThe United States of America Centers <strong>for</strong> Disease <strong>Control</strong><strong>and</strong> PreventionUSAIDWHOUnited States Agency <strong>for</strong> International DevelopmentWorld Health Organization3


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificAcknowledgementsThe <strong>Malaria</strong>, o<strong>the</strong>r Vectorborne <strong>and</strong> Parasitic Diseases unit of <strong>the</strong> WHO <strong>Regional</strong> Office <strong>for</strong> <strong>the</strong> WesternPacific wishes to acknowledge with gratitude <strong>the</strong> significant <strong>in</strong>puts from <strong>the</strong> national malaria programmemanagers <strong>and</strong> representatives from <strong>the</strong> m<strong>in</strong>istries of health from <strong>the</strong> 10 malaria-endemic Member Statesof <strong>the</strong> Western Pacific Region (Cambodia, Ch<strong>in</strong>a, <strong>the</strong> Lao People‘s Democratic Republic, Malaysia, PapuaNew Gu<strong>in</strong>ea, <strong>the</strong> Philipp<strong>in</strong>es, <strong>the</strong> Republic of Korea, Solomon Isl<strong>and</strong>s, Vanuatu <strong>and</strong> Viet Nam) <strong>and</strong> twoMember States from <strong>the</strong> WHO South-East Asia Region (Myanmar <strong>and</strong> Thail<strong>and</strong>).In addition, we acknowledge <strong>the</strong> collaboration of key stakeholders who were represented <strong>in</strong> severalmeet<strong>in</strong>gs dur<strong>in</strong>g <strong>the</strong> entire plann<strong>in</strong>g process. These <strong>in</strong>clude <strong>the</strong> Asia Pacific <strong>Malaria</strong> <strong>Elim<strong>in</strong>ation</strong> Network,<strong>the</strong> Asian Collaborative Tra<strong>in</strong><strong>in</strong>g Network <strong>for</strong> <strong>Malaria</strong>, <strong>the</strong> Australian Agency <strong>for</strong> International Development,<strong>the</strong> Eijkman-Ox<strong>for</strong>d Cl<strong>in</strong>ical Research Unit/Jakarta, <strong>the</strong> Global Fund to Fight AIDS, Tuberculosis <strong>and</strong> <strong>Malaria</strong>,<strong>the</strong> <strong>Malaria</strong> Consortium, Measure/EVALUATION, <strong>the</strong> Secretariat of <strong>the</strong> Pacific Community, <strong>the</strong> ResearchInstitute <strong>for</strong> Tropical Medic<strong>in</strong>e of <strong>the</strong> Philipp<strong>in</strong>es, <strong>the</strong> Roll Back <strong>Malaria</strong> Partnership, <strong>the</strong> Shell Foundation/Philipp<strong>in</strong>es, <strong>the</strong> Tropical Disease Foundation/Philipp<strong>in</strong>es, <strong>the</strong> United States of America Agency <strong>for</strong>International Development, <strong>the</strong> United States of America Centers <strong>for</strong> Disease <strong>Control</strong> <strong>and</strong> Prevention <strong>and</strong><strong>the</strong> University of Queensl<strong>and</strong>/Australia.We would like to acknowledge <strong>the</strong> significant <strong>in</strong>puts from WHO headquarters, WHO South-East AsiaRegion <strong>and</strong> WHO Mekong <strong>Malaria</strong> Programme as well as <strong>the</strong> contributions of Dr John Storey<strong>and</strong> Dr Sean Hewitt.Photo credits:Harrikrisna Anenden (page 8, left photo; page 22 left photo; <strong>and</strong> page 24, right photo).M<strong>in</strong>istry of Health Malaysia (page 11, left photo <strong>and</strong> page 26, left photo). You Yom (page 12, right photo).Lu M<strong>in</strong>g (page 18, right photo). Muhammad Shafique (page 31, right photo). WPRO Image Bank (page 24,left photo <strong>and</strong> page 25 photos). All o<strong>the</strong>r photos not credited were contributed by staff of <strong>the</strong> <strong>Regional</strong> <strong>and</strong>Country Offices.Graphic design:We also acknowledge with gratitude <strong>the</strong> graphic design work <strong>for</strong> this publication, which was done by© Ms Silvia Kirchhof, Munich, Germany.4


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificPrefaceThe Western Pacific Region has made considerable progress <strong>in</strong> recent decades <strong>in</strong> reduc<strong>in</strong>g malaria mortality<strong>and</strong> morbidity. Currently, 10 of <strong>the</strong> 37 countries <strong>and</strong> areas of <strong>the</strong> Region are endemic with <strong>the</strong> disease. In 2009,255 593 confirmed malaria cases <strong>and</strong> a total of 1031 malaria deaths were reported by public sector healthfacilities. However, many cases <strong>and</strong> deaths were not recorded. From 2000 to 2009,<strong>the</strong> number of confirmed malaria cases was reduced by 36%, with a 56% decl<strong>in</strong>e <strong>in</strong> malaria deaths.<strong>Malaria</strong> <strong>in</strong>cidence is reduced to such an extent that several countries are already mov<strong>in</strong>g towards malariaelim<strong>in</strong>ation. This transition will require careful plann<strong>in</strong>g <strong>and</strong> guidance. To meet <strong>the</strong>se needs, Member Stateshave endorsed <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific (2010– 2015) through resolution WPR/RC60.R5 of <strong>the</strong> sixtieth session of <strong>the</strong> WHO <strong>Regional</strong> Committee <strong>for</strong> <strong>the</strong>Western Pacific <strong>in</strong> September 2009. The plan is a product of extensive consultations <strong>and</strong> <strong>for</strong>ums amongnational programmes <strong>and</strong> multiple stakeholders, which considered <strong>the</strong> lessons learnt <strong>and</strong> available evidencefrom decades of implementation <strong>in</strong> <strong>the</strong> Region. The result is a plan with a clear goal <strong>and</strong> objectives <strong>and</strong>evidence-based <strong>in</strong>terventions. It also conta<strong>in</strong>s a regional malaria <strong>in</strong>dicator framework to track implementationprogress <strong>and</strong> measure <strong>in</strong>tended results.Affected countries are expected to use this strategic plan, which is subject to periodic review, as a guide toreview <strong>and</strong> update national malaria strategies to scale up control <strong>and</strong> <strong>in</strong>clude elim<strong>in</strong>ation objectives.The updated national plans will serve as advocacy tools to mobilize resources both <strong>in</strong>ternally <strong>and</strong> externally.Also, it should identify challenges <strong>and</strong> opportunities <strong>for</strong> malaria control <strong>and</strong> elim<strong>in</strong>ation <strong>in</strong> <strong>the</strong> Region.To implement <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific(2010 – 2015) most successfully, it will be important that Member States streng<strong>the</strong>n <strong>the</strong>ir health systems to beable to susta<strong>in</strong> ga<strong>in</strong>s achieved so far <strong>and</strong> fur<strong>the</strong>r accelerate movement towards elim<strong>in</strong>ation.WHO strongly supports national malaria programmes <strong>and</strong> o<strong>the</strong>r stakeholders <strong>in</strong> <strong>the</strong>ir cont<strong>in</strong>u<strong>in</strong>g ef<strong>for</strong>ts toimplement proven, cost-effective strategies <strong>and</strong> <strong>in</strong>terventions that will accelerate malaria elim<strong>in</strong>ation from ourRegion.Sh<strong>in</strong> Young-soo, MD, Ph.D.<strong>Regional</strong> Director5


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific<strong>Regional</strong> Committee Resolution WPR/RC60.R5, 2009The <strong>Regional</strong> Committee,Concerned that malaria rema<strong>in</strong>s a significant public health problem <strong>in</strong> <strong>the</strong> Region, especially <strong>for</strong> <strong>the</strong> poorestrural populations;Acknowledg<strong>in</strong>g progress made by Member States <strong>in</strong> reduc<strong>in</strong>g malaria mortality <strong>and</strong> morbidity, withseveral Members States hav<strong>in</strong>g changed <strong>the</strong>ir national malaria programme goals from malaria control toelim<strong>in</strong>ation;Aware of <strong>the</strong> unacceptably high burden of malaria <strong>in</strong> a few countries, <strong>the</strong> cont<strong>in</strong>ued transmission <strong>in</strong> activefoci <strong>in</strong> many countries <strong>and</strong> <strong>the</strong> risk of malaria epidemics;Concerned with <strong>the</strong> emergence of artemis<strong>in</strong><strong>in</strong> resistance <strong>in</strong> Plasmodium falciparum as a major global threatto malaria control <strong>and</strong> elim<strong>in</strong>ation;Fur<strong>the</strong>r concerned with <strong>the</strong> wide availability of subst<strong>and</strong>ard <strong>and</strong> counterfeit antimalarial medic<strong>in</strong>es <strong>and</strong> <strong>the</strong>irrational use of artemis<strong>in</strong><strong>in</strong> derivatives, especially <strong>in</strong> <strong>the</strong> private sector;Recogniz<strong>in</strong>g <strong>the</strong> public health significance <strong>in</strong> <strong>the</strong> Western Pacific Region of malaria caused by Plasmodiumvivax, which currently is not adequately diagnosed <strong>and</strong> treated <strong>in</strong> many countries <strong>and</strong> which poses aparticular challenge <strong>for</strong> malaria elim<strong>in</strong>ation;Acknowledg<strong>in</strong>g <strong>the</strong> unprecedented amount of fund<strong>in</strong>g made available <strong>for</strong> malaria control <strong>and</strong> elim<strong>in</strong>ation;Fur<strong>the</strong>r acknowledg<strong>in</strong>g <strong>the</strong> need to streng<strong>the</strong>n human resources <strong>and</strong> national surveillance systems <strong>and</strong> tosusta<strong>in</strong> fund<strong>in</strong>g <strong>for</strong> malaria;Recogniz<strong>in</strong>g that effective malaria control <strong>and</strong> elim<strong>in</strong>ation require universal access of all at-risk populationsto effective prevention, diagnosis <strong>and</strong> treatment measures as well as strong community <strong>in</strong>volvement;Aware of <strong>the</strong> importance of partnerships <strong>and</strong> <strong>in</strong>tersectoral cooperation to achieve programme goals <strong>and</strong>more cost-effective <strong>in</strong>terventions through synergies;Recogniz<strong>in</strong>g <strong>the</strong> importance of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> WesternPacific (2010 – 2015) 1 as a road map to guide national programmes, as a monitor<strong>in</strong>g framework <strong>and</strong> as anadvocacy <strong>and</strong> resource mobilization tool;1Annex 1 of document WPR/RC60/86


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific1. ENDORSES <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific(2010 – 2015);2. URGES Member States where malaria is endemic:(1) to use <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific(2010 – 2015) to update national malaria control or elim<strong>in</strong>ation plans <strong>and</strong> as a framework <strong>for</strong>monitor<strong>in</strong>g implementation <strong>and</strong> mobiliz<strong>in</strong>g resources;(2) to streng<strong>the</strong>n commitment at all levels to help ensure that adequate human <strong>and</strong> f<strong>in</strong>ancial resourcesare made available to implement <strong>and</strong> susta<strong>in</strong> national malaria control or elim<strong>in</strong>ation programmes<strong>and</strong> <strong>in</strong>corporate health system streng<strong>the</strong>n<strong>in</strong>g whenever feasible;(3) to ensure universal access <strong>for</strong> all at-risk populations to appropriate <strong>and</strong> effective vector controlmeasures, early parasite-based diagnosis <strong>and</strong> safe <strong>and</strong> effective antimalarial treatment <strong>and</strong> tomaximize services utilization through appropriate communication <strong>and</strong> community mobilization;(4) to prohibit <strong>the</strong> market<strong>in</strong>g of artemis<strong>in</strong><strong>in</strong>-based mono<strong>the</strong>rapies <strong>and</strong> halt any fur<strong>the</strong>r development <strong>and</strong>spread of artemis<strong>in</strong><strong>in</strong>-resistant falciparum malaria;(5) to improve diagnosis <strong>and</strong> treatment of vivax malaria, <strong>in</strong>clud<strong>in</strong>g address<strong>in</strong>g <strong>the</strong> issue of glucose-6-phosphate dehydrogenase deficiency <strong>and</strong> support<strong>in</strong>g operational research to fill knowledge gaps;(6) to streng<strong>the</strong>n national surveillance systems to monitor malaria trends <strong>and</strong> programme impact,to detect <strong>and</strong> control outbreaks <strong>in</strong> a timely manner <strong>and</strong> to encourage regular <strong>and</strong> transparent datareport<strong>in</strong>g <strong>and</strong> shar<strong>in</strong>g;(7) to foster partnerships with nongovernmental organizations <strong>and</strong> technical agencies <strong>and</strong> support<strong>in</strong>tersectoral cooperation;3. REQUESTS <strong>the</strong> <strong>Regional</strong> Director:(1) to use <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific Region(2010 – 2015) to advocate among stakeholders <strong>and</strong> development partners <strong>for</strong> <strong>in</strong>creased support<strong>for</strong> mov<strong>in</strong>g from malaria control towards a malaria-free Region;(2) to provide technical support to Member States to address barriers to <strong>the</strong> scal<strong>in</strong>g up of malariacontrol <strong>and</strong> elim<strong>in</strong>ation programmes;(3) to report to <strong>the</strong> <strong>Regional</strong> Committee about progress <strong>in</strong> implement<strong>in</strong>g <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong><strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific (2010 – 2015) <strong>and</strong> to report on necessaryref<strong>in</strong>ements, as required.7


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificSummary<strong>Malaria</strong> contributes significantly to child <strong>and</strong>maternal morbidity <strong>and</strong> mortality. There<strong>for</strong>e,<strong>the</strong> success of <strong>the</strong> fight aga<strong>in</strong>st malariaimpacts positively on <strong>the</strong> achievement of<strong>the</strong> United Nations Millennium DevelopmentGoals. <strong>Malaria</strong> is directly related to MDG 6(combat<strong>in</strong>g HIV/AIDS, malaria, tuberculosis<strong>and</strong> o<strong>the</strong>r diseases). It is l<strong>in</strong>ked <strong>in</strong>directly toMDG 4 (reduc<strong>in</strong>g child mortality) <strong>and</strong> MDG 5(improv<strong>in</strong>g maternal health) <strong>and</strong> remotelyrelated to o<strong>the</strong>r goals such as eradicat<strong>in</strong>gextreme poverty <strong>and</strong> hunger (MDG 1), ensur<strong>in</strong>genvironmental susta<strong>in</strong>ability (MDG 7) <strong>and</strong> build<strong>in</strong>ga global partnership <strong>for</strong> development (MDG 8).Effective control of malaria is exceptionally challeng<strong>in</strong>g <strong>in</strong><strong>the</strong> 10 endemic countries of <strong>the</strong> Western Pacific Region:Cambodia, Ch<strong>in</strong>a, <strong>the</strong> Lao People‘s DemocraticRepublic, Malaysia, Papua New Gu<strong>in</strong>ea, <strong>the</strong> Philipp<strong>in</strong>es,<strong>the</strong> Republic of Korea, Solomon Isl<strong>and</strong>s, Vanuatu <strong>and</strong>Viet Nam. The epidemiology of <strong>the</strong> disease is extremelyvariable <strong>and</strong> different situations require differentmalaria control strategies adapted to various risk groups,vector behaviours, local health <strong>in</strong>frastructure <strong>and</strong>environmental conditions. Multidrug-resistantPlasmodium falciparum <strong>and</strong> <strong>the</strong> presence of<strong>in</strong>appropriate, subst<strong>and</strong>ard <strong>and</strong> counterfeit antimalarialmedic<strong>in</strong>es add considerably to <strong>the</strong> difficultiesassociated with this complex situation.8


Despite <strong>the</strong>se difficulties, many countries <strong>in</strong> <strong>the</strong>Western Pacific Region dur<strong>in</strong>g <strong>the</strong> last decadehave been very successful <strong>in</strong> reduc<strong>in</strong>g <strong>the</strong> burdenof malaria. From 2000 to 2009, mortality <strong>in</strong> <strong>the</strong>Region was reduced by 36% <strong>and</strong> <strong>the</strong> number ofconfirmed malaria cases was reduced by 56%.Never<strong>the</strong>less, <strong>the</strong> burden of disease rema<strong>in</strong>sunacceptably high <strong>in</strong> some countries.Hyperendemic foci can still be found <strong>in</strong> manycountries, <strong>and</strong> <strong>the</strong> situation is particularly<strong>Malaria</strong> control <strong>and</strong> elim<strong>in</strong>ation ef<strong>for</strong>ts <strong>in</strong> <strong>the</strong> Regionstill face a daunt<strong>in</strong>g array of challenges relat<strong>in</strong>g bothto technical <strong>and</strong> programmatic issues, to political <strong>and</strong>economic constra<strong>in</strong>ts, to environmentalchanges <strong>and</strong> to <strong>the</strong> rapidly evolv<strong>in</strong>g donor <strong>and</strong>partner l<strong>and</strong>scape. In addition, <strong>the</strong> new <strong>and</strong> longoverdue emphasis on improv<strong>in</strong>g <strong>the</strong> quality of malariadiagnostic <strong>and</strong> treatment services provided by <strong>the</strong>private sector places a considerable extra burden on<strong>the</strong> various partners <strong>in</strong>volved.serious <strong>in</strong> Papua New Gu<strong>in</strong>ea. Fur<strong>the</strong>r,<strong>the</strong> risk of a significant resurgence of malaria rema<strong>in</strong>svery real <strong>in</strong> several areas.At <strong>the</strong> same time, <strong>the</strong> political profile of malaria has risendramatically s<strong>in</strong>ce 2000 <strong>and</strong> fund<strong>in</strong>g has grown at anextraord<strong>in</strong>ary rate, mak<strong>in</strong>g this a time of great opportunity.9


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificSummaryEf<strong>for</strong>ts are now needed to fur<strong>the</strong>r exp<strong>and</strong>coverage <strong>and</strong> streng<strong>the</strong>n <strong>the</strong> delivery of exist<strong>in</strong>gservices. Cont<strong>in</strong>ued <strong>in</strong>novation is needed tomaximize coverage of hard-to-reach populationsvivax malaria. There needs to be an <strong>in</strong>creasedemphasis on regional collaboration <strong>and</strong> onmultisectoral ef<strong>for</strong>ts if required out comesare to be achieved.at greatest risk. An immediate priority issueis halt<strong>in</strong>g <strong>the</strong> development <strong>and</strong> prevent<strong>in</strong>g <strong>the</strong> spreadof artemis<strong>in</strong><strong>in</strong>-resistant malaria parasites <strong>in</strong> <strong>the</strong> borderareas of Cambodia, Thail<strong>and</strong> <strong>and</strong> <strong>in</strong> Sou<strong>the</strong>rn VietNam. Ano<strong>the</strong>r important <strong>Regional</strong>focus over <strong>the</strong> next five years will be build<strong>in</strong>g atransition towards phased malaria elim<strong>in</strong>ation<strong>and</strong> one prerequisite will be to f<strong>in</strong>d feasiblestrategies to implement a radical cure <strong>for</strong>The <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific (2010 – 2015)will be <strong>the</strong> Region‘s malaria road map <strong>for</strong> <strong>the</strong> nextsix years. The proposed regional goal is to reducemalaria mortality <strong>and</strong> morbidity by 50% by 2015compared with 2007 <strong>and</strong> to achieve <strong>the</strong> <strong>in</strong>terruptionof malaria transmission <strong>in</strong> targeted areas <strong>in</strong> at leastseven countries.10


The <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> is <strong>the</strong> result ofextensive consultations <strong>and</strong> <strong>for</strong>ums <strong>in</strong>volv<strong>in</strong>gnational programmes <strong>and</strong> multiple stakeholders.It was endorsed by Member States at <strong>the</strong>is expected to serve not only as a framework<strong>for</strong> updat<strong>in</strong>g national plans but also as a tool <strong>for</strong>monitor<strong>in</strong>g national programmes <strong>and</strong> <strong>for</strong> mobiliz<strong>in</strong>g<strong>in</strong>ternal <strong>and</strong> external resources.sixtieth session of <strong>the</strong> WHO <strong>Regional</strong> Committee<strong>for</strong> <strong>the</strong> Western Pacific on 24 September 2009under resolution WPR/RC60.R5. It is <strong>in</strong> l<strong>in</strong>e with <strong>the</strong>MDGs, resolution WHA60.18 adopted by <strong>the</strong> WorldHealth Assembly on 23 May 2007 <strong>and</strong><strong>the</strong> Roll Back <strong>Malaria</strong> Partnership‘sGlobal <strong>Malaria</strong> <strong>Action</strong> <strong>Plan</strong> <strong>and</strong> resolutionA/RES/63/234 of <strong>the</strong> United Nations GeneralAssembly, adopted 13 March 2009. The plan11


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific<strong>Malaria</strong> situation <strong>in</strong> <strong>the</strong> Western Pacific RegionAlthough sub-Saharan Africa bears <strong>the</strong> greatest burdenof malaria, <strong>the</strong> health <strong>and</strong> economicimpact of <strong>the</strong> disease <strong>in</strong> <strong>the</strong> Western Pacific Regionrema<strong>in</strong>s considerable. In all, 255 593 confirmed casesof malaria were reported by public sector healthfacilities <strong>in</strong> 2009. A total of 1031 malaria deaths werereported that year. However, lowcoverage of diagnostic services <strong>in</strong> some countries<strong>and</strong> low reliance on public health services <strong>in</strong> o<strong>the</strong>rs,exacerbated by low public sectorcoverage <strong>in</strong> many high transmission areas,mean that <strong>the</strong>se figures grossly underestimate<strong>the</strong> true burden of malaria.Effective control of malaria <strong>in</strong> <strong>the</strong> Western PacificRegion is exceptionally challeng<strong>in</strong>g. Epidemiologicalpatterns can be divided broadly <strong>in</strong>to four groupsaccord<strong>in</strong>g to geographical location: central Ch<strong>in</strong>a <strong>and</strong><strong>the</strong> Republic of Korea, <strong>the</strong> Philipp<strong>in</strong>es <strong>and</strong> Malaysia,<strong>the</strong> Mekong region <strong>and</strong> Melanesia, <strong>and</strong> Polynesia. Buteven with<strong>in</strong> <strong>the</strong>se broad divisions, <strong>the</strong> epidemiology of<strong>the</strong> disease varies considerably from one populationgroup to ano<strong>the</strong>r <strong>and</strong>, <strong>in</strong> manycases, <strong>the</strong> different situations require different malariacontrol strategies adapted to risk group <strong>and</strong> vectorbehaviour, local health <strong>in</strong>frastructure <strong>and</strong> environmentalconditions.12


Multidrug-resistant Plasmodium falciparum <strong>and</strong><strong>the</strong> counterfeit drugs add considerably to <strong>the</strong>control <strong>in</strong>to community-based health systems, havebeen key elements of this success.difficulties associated with this complexsituation. Never<strong>the</strong>less, many countries <strong>in</strong> <strong>the</strong>Western Pacific Region dur<strong>in</strong>g <strong>the</strong> last decadehave been very successful <strong>in</strong> reduc<strong>in</strong>g <strong>the</strong> burdenof malaria. Between 2000 <strong>and</strong> 2009, malariamortality was reduced by 36% <strong>and</strong> confirmedmalaria cases were reduced by 56%. Strongpolitical commitment, grow<strong>in</strong>g technical expertise, <strong>the</strong>availability of fund<strong>in</strong>g <strong>and</strong>, <strong>the</strong>re<strong>for</strong>e, <strong>the</strong>availability of supplies, <strong>in</strong>clud<strong>in</strong>g antimalarialmedic<strong>in</strong>es, diagnostics <strong>and</strong> <strong>in</strong>secticide-treatedmosquito nets, <strong>and</strong> <strong>the</strong> <strong>in</strong>tegration of malariaThe ma<strong>in</strong> strategies have <strong>in</strong>cluded improv<strong>in</strong>g access toprompt diagnosis <strong>and</strong> appropriate treatment services,ensur<strong>in</strong>g high coverage with <strong>in</strong>secticide-treated nets <strong>and</strong>,<strong>in</strong> some countries, focal <strong>in</strong>door residual spray<strong>in</strong>g with<strong>in</strong>secticides <strong>for</strong> vector control. Ef<strong>for</strong>tsrelated to improv<strong>in</strong>g knowledge <strong>and</strong> promot<strong>in</strong>gbehaviour change among target groups have resulted <strong>in</strong><strong>in</strong>creased use of services. In addition, socio-economicdevelopment has contributed substantially to <strong>the</strong>decl<strong>in</strong>e of malaria. De<strong>for</strong>estation also has played asignificant role <strong>in</strong> reduc<strong>in</strong>g transmission <strong>in</strong> many areas.13


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific<strong>Malaria</strong> situation <strong>in</strong> <strong>the</strong> Western Pacific RegionThe evolution of malaria control <strong>in</strong>terventions is acont<strong>in</strong>uous process <strong>and</strong> a range of highly effectivenew tools <strong>and</strong> <strong>in</strong>novative approaches to servicedelivery are revolutioniz<strong>in</strong>g malaria control ef<strong>for</strong>tsglobally. Many of <strong>the</strong>se new tools <strong>and</strong> approacheswere pioneered <strong>in</strong> <strong>the</strong> Western Pacific Region dur<strong>in</strong>gSupport <strong>for</strong> <strong>the</strong> provision of health care through<strong>the</strong> private sector <strong>and</strong> through community-basedvolunteer networks massively has improved<strong>the</strong> coverage of <strong>the</strong>se new malaria controlmeasures <strong>and</strong> <strong>the</strong> malaria situation <strong>in</strong> manycountries.<strong>the</strong> 1990s. Long last<strong>in</strong>g <strong>in</strong>secticidal nets, easy-tousemalaria rapid diagnostic tests, artemis<strong>in</strong><strong>in</strong>-basedcomb<strong>in</strong>ation <strong>the</strong>rapies <strong>and</strong> heat-stable suppositoriesconta<strong>in</strong><strong>in</strong>g artemis<strong>in</strong><strong>in</strong> derivatives are all hav<strong>in</strong>g aprofound impact on <strong>the</strong> prevention diagnosis, <strong>and</strong>treatment of malaria <strong>in</strong> <strong>the</strong> Region <strong>and</strong> beyond.14


Key challenges <strong>and</strong> opportunitiesAlthough <strong>the</strong>re recently has been an overallimprovement <strong>in</strong> <strong>the</strong> malaria situation <strong>in</strong> <strong>the</strong>Western Pacific Region, <strong>the</strong> burden of diseaserema<strong>in</strong>s unacceptably high. Hyperendemic foci stillcan be found <strong>in</strong> many countries, <strong>and</strong> <strong>in</strong>Papua New Gu<strong>in</strong>ea <strong>the</strong> situation is particularlyserious. Fur<strong>the</strong>r, <strong>the</strong> risk of a significant resurgenceof malaria rema<strong>in</strong>s very real <strong>in</strong> several areas. <strong>Malaria</strong>Moreover, <strong>the</strong> new <strong>and</strong> long overdue emphasison improv<strong>in</strong>g <strong>the</strong> quality of malaria diagnostic <strong>and</strong>treatment services provided by <strong>the</strong> private sectorplaces a considerable extra burden on <strong>the</strong> variouspartners <strong>in</strong>volved. At <strong>the</strong> same time, <strong>the</strong> politicalprofile of malaria has risen dramatically s<strong>in</strong>ce 2000<strong>and</strong> fund<strong>in</strong>g has grown at an extraord<strong>in</strong>ary rate,mak<strong>in</strong>g this a time of great opportunity.control <strong>and</strong> elim<strong>in</strong>ation ef<strong>for</strong>ts <strong>in</strong> <strong>the</strong>Western Pacific Region still face a daunt<strong>in</strong>g arrayof challenges relat<strong>in</strong>g both to technical <strong>and</strong>programmatic issues, to political <strong>and</strong> economicconstra<strong>in</strong>ts, to environmental changes <strong>and</strong> to <strong>the</strong>rapidly evolv<strong>in</strong>g donor <strong>and</strong> partner l<strong>and</strong>scape.15


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificKey challenges <strong>and</strong> opportunitiesThe key issues fac<strong>in</strong>g malaria control <strong>in</strong> <strong>the</strong> Region are many <strong>and</strong> varied:Diagnosis plays a central role <strong>for</strong> <strong>the</strong> rational treatmentof malaria (<strong>and</strong> non-malarial fevers), yet diagnosticissues have been given low priority by someprogrammes <strong>and</strong> fund<strong>in</strong>g agencies. Presumptiveantimalarial treatment <strong>for</strong> any fever with no obviousalternative cause is widely practised <strong>and</strong> leads tosignificant overuse of antimalarial medic<strong>in</strong>es. Withartemis<strong>in</strong><strong>in</strong>-based comb<strong>in</strong>ation <strong>the</strong>rapy now <strong>the</strong>first l<strong>in</strong>e treatment <strong>for</strong> malaria, this high level ofoverdiagnosis has serious cost implications. It also hasvery serious health implications because it isassociated with a failure to adequately treatalternative causes of <strong>in</strong>fection.Oral artemis<strong>in</strong><strong>in</strong> mono<strong>the</strong>rapy cont<strong>in</strong>ues to be widelyavailable <strong>in</strong> <strong>the</strong> Region, exert<strong>in</strong>g pressure <strong>for</strong> <strong>the</strong>selection of artemis<strong>in</strong><strong>in</strong>-resistant parasites.Artemis<strong>in</strong><strong>in</strong>-resistant falciparum malaria hasemerged along <strong>the</strong> Cambodia-Thail<strong>and</strong> border <strong>and</strong><strong>in</strong> <strong>the</strong> south of Viet Nam. All of WHO’s recommendedregimens <strong>for</strong> <strong>the</strong> management of uncomplicatedfalciparum malaria globally are now dependent onartemis<strong>in</strong><strong>in</strong>-based comb<strong>in</strong>ation <strong>the</strong>rapies, <strong>and</strong> <strong>the</strong>reare currently no viable alternatives.The spread ofartemis<strong>in</strong><strong>in</strong>-resistant P. falciparum would havedisastrous consequences on malaria treatment <strong>and</strong>elim<strong>in</strong>ation globally.16


The cont<strong>in</strong>u<strong>in</strong>g artemis<strong>in</strong><strong>in</strong>-resistance conta<strong>in</strong>mentef<strong>for</strong>t <strong>in</strong> <strong>the</strong> Region is <strong>the</strong>re<strong>for</strong>e a global priority.Evidence is emerg<strong>in</strong>g that vivax malaria may not beas benign as previously thought. Because of <strong>the</strong>existence of dormant liver stages, vivax malaria isCounterfeit antimalarials are still be<strong>in</strong>g produced<strong>and</strong> marketed <strong>in</strong> <strong>the</strong> Region, but multisectoral ef<strong>for</strong>tsto halt this are now advanc<strong>in</strong>g. In 2007, OperationJupiter, an <strong>in</strong>ternational collaboration betweenscientists, public health workers <strong>and</strong> police, led to <strong>the</strong>arrest of producers <strong>and</strong>distributors of fake artesunate. Investigationscoord<strong>in</strong>ated by Interpol <strong>in</strong> cooperation with WHO <strong>and</strong>partners are cont<strong>in</strong>u<strong>in</strong>g.more difficult to control than falciparum malaria.As a result <strong>and</strong> as control ef<strong>for</strong>ts <strong>in</strong> <strong>the</strong> Regionadvance, it is pro gressively becom<strong>in</strong>g <strong>the</strong>predom<strong>in</strong>ant malaria species. The situation is fur<strong>the</strong>rcomplicated <strong>in</strong> nor<strong>the</strong>rn areas of <strong>the</strong> Region by stra<strong>in</strong>sof P. vivax, which are characterized by laterelapses (which may occur years after <strong>in</strong>itial<strong>in</strong>fection). In addition, high <strong>in</strong>cidence of glucose 6phosphate dehydrogenase (G6PD) deficiency 11This enzyme deficiency can lead to a potentially fatal reaction to primaqu<strong>in</strong>e, <strong>the</strong> only drugcurrently available <strong>for</strong> <strong>the</strong> treatment of <strong>the</strong> dormant liver stages of vivax malaria.17


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificKey challenges <strong>and</strong> opportunities<strong>in</strong> <strong>the</strong> human population <strong>in</strong> some areas precludes<strong>the</strong> general use of primaqu<strong>in</strong>e, <strong>the</strong> only drugcurrently available <strong>for</strong> <strong>the</strong> radical cure of vivaxmalaria. More emphasis needs to be placed onto be achieved. A comprehensive policy <strong>for</strong>private sector streng<strong>the</strong>n<strong>in</strong>g provid<strong>in</strong>g clear <strong>and</strong>locally appropriate strategies needs to be<strong>for</strong>mulated urgently.develop<strong>in</strong>g effective tools <strong>for</strong> vivax control <strong>and</strong>elim<strong>in</strong>ation.Although <strong>the</strong> use of conventional bednets is high <strong>in</strong>most countries, <strong>in</strong>secticide-treated bednet coverageThe private sector plays a major role <strong>in</strong> pro vid<strong>in</strong>ghealth care <strong>in</strong> many countries; however, <strong>the</strong> servicesoffered are often critically weak. Engag<strong>in</strong>g <strong>the</strong>overall is still low <strong>in</strong> <strong>the</strong> Region. Increas<strong>in</strong>g coveragewith long last<strong>in</strong>g <strong>in</strong>secticidal nets should <strong>the</strong>re<strong>for</strong>e bea primary objective of future ef<strong>for</strong>ts.private sector represents a huge opportunity todecisively improve health care delivery across <strong>the</strong>board <strong>and</strong> must be a key focus over <strong>the</strong> next fewyears if malaria control <strong>and</strong> elim<strong>in</strong>ation targets areDespite recent improvements to road networks <strong>in</strong>many countries <strong>in</strong> <strong>the</strong> Region, accessibility rema<strong>in</strong>s<strong>the</strong> key issue <strong>for</strong> some. The many diferent categories18


of mobile groups <strong>in</strong> <strong>the</strong> Region present a particularchallenge to health services. They are difficult totarget <strong>and</strong> malaria prevention tools such as longlast<strong>in</strong>g <strong>in</strong>secticidal nets <strong>and</strong> delivery mechanisms suchas community-based diagnostic <strong>and</strong> treatmentservices are not well-suited to <strong>the</strong>ir transient nature.Major development projects such as hydro electric dams,new roads, pipel<strong>in</strong>es <strong>and</strong> o<strong>the</strong>r large-scale<strong>in</strong>frastructure improvements can also lead to <strong>the</strong>creation of important new transmission foci, as canchang<strong>in</strong>g agricultural practices <strong>and</strong> m<strong>in</strong><strong>in</strong>g activities.National programmes need to ma<strong>in</strong>ta<strong>in</strong> a high degree ofvigilance <strong>and</strong> work closely with multisectoralEarly <strong>in</strong>dications from Papua New Gu<strong>in</strong>ea suggest thatglobal warm<strong>in</strong>g may be result<strong>in</strong>g <strong>in</strong> <strong>in</strong>creased malariapartners to prevent <strong>the</strong> development of newtransmission foci.transmission <strong>in</strong> <strong>the</strong> highl<strong>and</strong>s, where unstable seasonaltransmission is now found <strong>in</strong> areas that until recentlywere free of malaria. Programmes must monitorepidemio logical trends <strong>and</strong> respond promptly to anychanges that might occur.<strong>Regional</strong> policies relat<strong>in</strong>g to a number of key issuessuch as malaria <strong>in</strong> pregnancy, <strong>the</strong> role of <strong>the</strong> privatesector <strong>in</strong> malaria control <strong>and</strong> special <strong>in</strong>terventions <strong>for</strong>vulnerable groups are overdue.19


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificKey challenges <strong>and</strong> opportunitiesThis can be attributed largely to <strong>the</strong> scarcity ofquality operational research on <strong>the</strong>se key issues.This situation has been hampered <strong>in</strong> many countriestools <strong>and</strong> to adapt exist<strong>in</strong>g tools <strong>and</strong> associateddelivery strategies to suit <strong>the</strong> various targetpopulations at greatest risk.by <strong>the</strong> myriad of compet<strong>in</strong>g priorities <strong>and</strong> <strong>in</strong>sufficienttechnical capacity <strong>for</strong> operational research at <strong>the</strong>national level, sometimes fur<strong>the</strong>r complicated byuncoord<strong>in</strong>ated partner-driven research agendas.Even though <strong>the</strong> key issues listed above long havebeen a high priority, <strong>the</strong>re are still no effective malariacontrol measures <strong>for</strong> some vulnerable groups, suchAdequate human resources are crucial to achiev<strong>in</strong>gprogrammatic success. Staff<strong>in</strong>g levels with<strong>in</strong> mostnational malaria programmes fell dramatically <strong>in</strong> <strong>the</strong>post-eradication years. Although <strong>the</strong>re has been somerecovery <strong>in</strong> recent years, a serious shortfall rema<strong>in</strong>s <strong>in</strong>most endemic countries.as mobile populations. In addition, maternal <strong>and</strong> childhealth <strong>and</strong> mortality are still not adequately addressed.There is clearly a role <strong>for</strong> cont<strong>in</strong>ued<strong>in</strong>novation. Fur<strong>the</strong>r work is needed to develop newMost malaria programmes <strong>in</strong> <strong>the</strong> Region tend to bevertical <strong>in</strong> nature. The <strong>in</strong>tegration of activities is generallylimited <strong>and</strong> valuable opportunities <strong>for</strong> synergy often20


are lost as a result. The massive <strong>in</strong>crease <strong>in</strong> fund<strong>in</strong>gearmarked <strong>for</strong> malaria as a consequence of its recentprioritization on <strong>the</strong> global health agenda may <strong>in</strong>creasethis verticality unless special means are established toacross health programmes <strong>in</strong> order to take full advantageof all opportunities <strong>for</strong> life-sav<strong>in</strong>g synergies betweenmalaria <strong>and</strong> o<strong>the</strong>r health <strong>in</strong>itiatives <strong>and</strong> to streng<strong>the</strong>nhealth systems generally.encourage programmes to <strong>in</strong>tegrate activities, whereappropriate. Many o<strong>the</strong>r areas are under-resourced.For example, village-based diagnosis <strong>and</strong> treatment<strong>for</strong> malaria is now availaleat <strong>the</strong> community level <strong>in</strong> many of <strong>the</strong> Region’stransmission hotspots, but children <strong>in</strong> <strong>the</strong>se samecommunities do not have access to treatment <strong>for</strong>acute respiratory tract <strong>in</strong>fections or diarrhoea. Greateref<strong>for</strong>ts are needed to work out practical mechanismsto operate <strong>in</strong>tegration effectivelyIt is especially difficult to susta<strong>in</strong> political commitment <strong>and</strong>ma<strong>in</strong>ta<strong>in</strong> fund<strong>in</strong>g levels as malaria control moves to malariaelim<strong>in</strong>ation <strong>and</strong> to <strong>the</strong> prevention of <strong>the</strong> re-<strong>in</strong>troduction ofmalaria. There are a number of well-documented cases <strong>in</strong>recent years <strong>in</strong> which a reduction <strong>in</strong> <strong>the</strong> malaria burden hasled to political complacency, withdrawal of fund<strong>in</strong>g <strong>and</strong>,ultimately, a major resurgence of disease. Strenuous ef<strong>for</strong>tswill be required to secure cont<strong>in</strong>ued fund<strong>in</strong>g as <strong>the</strong> malariasituation improves.21


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificKey challenges <strong>and</strong> opportunitiesPolitical factors also present a number of importantchallenges to malaria control <strong>and</strong> elim<strong>in</strong>ation <strong>in</strong> <strong>the</strong>Western Pacific Region. For example, unrest<strong>for</strong>mation of strategic partnerships <strong>and</strong> strongleadership of national programmes, will be requiredif <strong>the</strong>se problems are to be avoided.currently hampers local malaria control ef<strong>for</strong>ts <strong>in</strong> someparts of <strong>the</strong> Region.Ef<strong>for</strong>ts are needed to fur<strong>the</strong>r exp<strong>and</strong> coverage<strong>and</strong> streng<strong>the</strong>n <strong>the</strong> delivery of exist<strong>in</strong>g services,With so many new organizations now <strong>in</strong>volved <strong>in</strong>malaria control <strong>and</strong> with so many new partnerships<strong>and</strong> networks <strong>in</strong> existence, <strong>the</strong>re is a risk ofduplication of ef<strong>for</strong>ts, unnecessary competition,confusion <strong>and</strong> loss of strategic direction. Significantimprovements <strong>in</strong><strong>in</strong>teragency coord<strong>in</strong>ation, toge<strong>the</strong>r with <strong>the</strong><strong>in</strong>clud<strong>in</strong>g long last<strong>in</strong>g <strong>in</strong>secticidal nets, provid<strong>in</strong>ghealth facility-based public sector health care,community-based diagnostic <strong>and</strong> treatmentservices <strong>and</strong> provid<strong>in</strong>g private sector health care.Cont<strong>in</strong>ued <strong>in</strong>novation is needed to maximizecoverage, adapt<strong>in</strong>g newly-fashioned tools <strong>and</strong>service delivery mechanisms to suit <strong>the</strong> various22


target populations at greatest risk. Animmediate priority issue is halt<strong>in</strong>g <strong>the</strong> buildup <strong>and</strong>prevent<strong>in</strong>g <strong>the</strong> spread of artemis<strong>in</strong><strong>in</strong>-resistantmalaria parasites <strong>in</strong> border areas of Cambodia<strong>and</strong> Thail<strong>and</strong> <strong>and</strong> o<strong>the</strong>r areas with evidence ofartemis<strong>in</strong> <strong>in</strong> resistance. Ano<strong>the</strong>r importantregional focus over <strong>the</strong> next five years will besecur<strong>in</strong>g <strong>the</strong> way <strong>for</strong> a move towards phasedmalaria elim<strong>in</strong>ation. There will need to be<strong>in</strong>creased emphasis on regional collaboration<strong>and</strong> on multisectoral ef<strong>for</strong>ts if requiredoutcomes are to be achieved.23


Development of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>The <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific (2010 – 2015)is <strong>the</strong> result of extensive consultations <strong>and</strong><strong>for</strong>ums <strong>in</strong>volv<strong>in</strong>g national programmes <strong>and</strong> variousstakeholders. The issues described above were<strong>the</strong> Lao People‘s Democratic Republic, Malaysia,Papua New Gu<strong>in</strong>ea, <strong>the</strong> Philipp<strong>in</strong>es, <strong>the</strong> Republic ofKorea, Solomon Isl<strong>and</strong>s, Vanuatu <strong>and</strong> Viet Nam) <strong>and</strong>two Member States from <strong>the</strong> WHO South-East AsiaRegion (Myanmar <strong>and</strong> Thail<strong>and</strong>).discussed at various levels <strong>and</strong> <strong>the</strong> <strong>Action</strong> <strong>Plan</strong> wasput toge<strong>the</strong>r based on those discussions.The f<strong>in</strong>al draft was analysed <strong>and</strong> ref<strong>in</strong>ed <strong>in</strong> July2009 dur<strong>in</strong>g a five-day workshop attended bynational malaria programme managers <strong>and</strong>representatives from <strong>the</strong> m<strong>in</strong>istries of healthfrom <strong>the</strong> 10 malaria-endemic Member States of <strong>the</strong>Western Pacific Region (Cambodia, Ch<strong>in</strong>a,In addition, key stakeholders were represented,<strong>in</strong>clud<strong>in</strong>g APMEN, <strong>the</strong> Asian CollaborativeTra<strong>in</strong><strong>in</strong>g Network <strong>for</strong> <strong>Malaria</strong> (ACT<strong>Malaria</strong>),<strong>the</strong> Australian Agency <strong>for</strong> InternationalDevelopment (AusAID), <strong>the</strong> Eijkman-Ox<strong>for</strong>dCl<strong>in</strong>ical Research Unit/Jakarta, <strong>the</strong> Global Fund toFight AIDS, Tuberculosis <strong>and</strong> <strong>Malaria</strong>, <strong>the</strong> <strong>Malaria</strong>24


Consortium, Measure/EVALUATION, <strong>the</strong> Secretariatof <strong>the</strong> Pacific Community, <strong>the</strong> Research Institute <strong>for</strong>Tropical Medic<strong>in</strong>e of <strong>the</strong> Philipp<strong>in</strong>es, <strong>the</strong> Roll Back<strong>Malaria</strong> Partnership, <strong>the</strong> Shell Foundation/Philipp<strong>in</strong>es, <strong>the</strong> Tropical Disease Foundation/Philipp<strong>in</strong>es, USAID, <strong>the</strong> United States of AmericaIt is <strong>in</strong> l<strong>in</strong>e with <strong>the</strong> United Nations MDGs,resolution WHA60.18 adopted by <strong>the</strong> World HealthAssembly on 23 May 2007, <strong>the</strong> Roll Back <strong>Malaria</strong>Partnership‘s Global <strong>Malaria</strong> <strong>Action</strong> <strong>Plan</strong> <strong>and</strong>resolution A/RES/63/234 of <strong>the</strong> United NationsGeneral Assembly, adopted on 13 March 2009.Centers <strong>for</strong> Disease <strong>Control</strong> <strong>and</strong> Prevention <strong>and</strong><strong>the</strong> University of Queensl<strong>and</strong>/Australia.The <strong>Action</strong> <strong>Plan</strong> was endorsed by MemberStates at <strong>the</strong> sixtieth session of <strong>the</strong> WHO<strong>Regional</strong> Committee <strong>for</strong> <strong>the</strong> Western Pacific on24 September 2009 under resolution WPR/RC60.R5.25


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificRole of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>This <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong><strong>in</strong> <strong>the</strong> Western Pacific (2010 – 2015) will be<strong>the</strong> Region‘s malaria road map <strong>for</strong> <strong>the</strong> next six years.The <strong>Action</strong> <strong>Plan</strong> will not only serve as aframework <strong>for</strong> updat<strong>in</strong>g national plans but also as aIt sets out <strong>the</strong> goal, objectives <strong>and</strong> ma<strong>in</strong> activities,toge<strong>the</strong>r with goal- <strong>and</strong> objective-level <strong>in</strong>dicators<strong>and</strong> targets. Most of <strong>the</strong> <strong>in</strong>dicators <strong>in</strong> <strong>the</strong> <strong>Action</strong><strong>Plan</strong> are “global malaria <strong>in</strong>dicators” that are reported toWHO annually by all malaria-endemic countries.tool <strong>for</strong> monitor<strong>in</strong>g national programmes <strong>and</strong> <strong>for</strong>mobiliz<strong>in</strong>g <strong>in</strong>ternal <strong>and</strong> external resources.The <strong>Action</strong> <strong>Plan</strong> is a liv<strong>in</strong>g document that will beupdated periodically, as appropriate (<strong>the</strong> mostrecent version will be available onl<strong>in</strong>e at <strong>the</strong>Western Pacific <strong>Regional</strong> Office‘s malaria webpagehttp://www.wpro.who.<strong>in</strong>t/topics/malaria/enIn addition, a number of o<strong>the</strong>r <strong>in</strong>dicators have beenestablished dur<strong>in</strong>g extensive consultations <strong>and</strong><strong>in</strong>cluded to provide essential Region-specific <strong>in</strong><strong>for</strong>mation.The <strong>Regional</strong> <strong>Malaria</strong> Indicator Framework isbe<strong>in</strong>g used <strong>for</strong> country adaptation to review countrytargets <strong>in</strong> 2011.26


A detailed description of each <strong>in</strong>dicator will beavailable as an appendix to <strong>the</strong> <strong>Action</strong> <strong>Plan</strong> on <strong>the</strong>Western Pacific <strong>Regional</strong> Office‘s malaria web page.27


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificGoal, Objectives <strong>and</strong> Targets of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>The goal of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>The overall goal of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific (2010 –2015) is toconsolidate <strong>and</strong> build on <strong>the</strong> recent achievements <strong>in</strong> malaria control <strong>in</strong> <strong>the</strong> Region <strong>and</strong> progressively elim<strong>in</strong>ate malaria,where possible. This will be achieved through <strong>the</strong> implementation of activities grouped under seven objectives.The objectives of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>Objective 1Streng<strong>the</strong>n malaria programme management basedon firm political commitment <strong>and</strong> strong partnershipsIt will be achieved through comprehensive means.<strong>Malaria</strong> control policies, strategies, guidel<strong>in</strong>es <strong>and</strong> st<strong>and</strong>ardoperat<strong>in</strong>g procedures will be streng<strong>the</strong>ned. Legal frameworkswill be upgraded where necessary to support malariacontrol <strong>and</strong> elim<strong>in</strong>ation. Commitment to malaria controlwill be <strong>in</strong>creased at all levels through advocacy. Fund<strong>in</strong>gsources will be identified <strong>and</strong>adequate f<strong>in</strong>ancial support secured. Technical <strong>and</strong>adm<strong>in</strong>istrative management capacity will bestreng<strong>the</strong>ned through a comb<strong>in</strong>ation of recruitment <strong>and</strong>tra<strong>in</strong><strong>in</strong>g. Partner coord<strong>in</strong>ation will be improved <strong>and</strong> keytechnical support networks re<strong>in</strong><strong>for</strong>ced. Cross-bordercollaboration will be streng<strong>the</strong>ned. Programmaticmonitor<strong>in</strong>g <strong>and</strong> evaluation will be improved <strong>and</strong> needsbasedoperational research will be coord<strong>in</strong>ated tomaximize relevance <strong>and</strong> m<strong>in</strong>imize duplication.Objective 2Ensure full coverage of <strong>the</strong> population at risk withappropriate vector control measuresIt will be achieved through <strong>the</strong> implementation of two keystrategies: universal coverage of populations at risk withlong-last<strong>in</strong>g <strong>in</strong>secticidal nets <strong>and</strong> <strong>in</strong>secticide-treated bednets<strong>and</strong>, spray<strong>in</strong>g homes <strong>in</strong> selected areas withresidual <strong>in</strong>secticides. Support<strong>in</strong>g activities will <strong>in</strong>clude qualityassurance of <strong>in</strong>secticides <strong>and</strong> nett<strong>in</strong>g, riskmapp<strong>in</strong>g, streng<strong>the</strong>n<strong>in</strong>g <strong>the</strong> management <strong>and</strong> judicious useof <strong>in</strong>secticides <strong>and</strong> needs-based operationalresearch. Integrated vector management will beencouraged where feasible.28


Objective 3Objective 4Maximize utilization of malaria services (through appropriate<strong>in</strong><strong>for</strong>mation, education <strong>and</strong> communication<strong>and</strong>/or behaviour change communication) <strong>and</strong> dramaticallystreng<strong>the</strong>n community mobilization ef<strong>for</strong>tsIt will be achieved through <strong>the</strong> implementation of two keystrategies: comprehensive behaviour changecommunication <strong>and</strong> community mobilization. Bothstrategies will be supported by periodic evaluations<strong>and</strong> needs-based operational research.Ensure access <strong>for</strong> all to early diagnosis <strong>and</strong> af<strong>for</strong>dable,safe, effective <strong>and</strong> prompt antimalarial comb<strong>in</strong>ationtreatments through active public <strong>and</strong> privatesector <strong>in</strong>itiativesIt will be achieved through <strong>the</strong> implementation of two keystrategies through both public <strong>and</strong> private sector healthcare channels: provid<strong>in</strong>g quality parasite-based diagnosis<strong>and</strong> safe effective antimalarials <strong>for</strong> treatment of allspecies of malaria, <strong>in</strong>clud<strong>in</strong>g radical treatment <strong>for</strong> vivaxmalaria. Support<strong>in</strong>g activities will <strong>in</strong>clude capacity-build<strong>in</strong>g,supervision, quality assurance, rais<strong>in</strong>g awareness about <strong>the</strong>prevention of artemis<strong>in</strong><strong>in</strong> resistance <strong>and</strong> withdrawal of oralartemis<strong>in</strong><strong>in</strong> mono<strong>the</strong>rapy from <strong>the</strong> public <strong>and</strong> private sector,streng<strong>the</strong>n<strong>in</strong>g differential diagnosis of fevers, improv<strong>in</strong>gprocurement <strong>and</strong> supply management <strong>and</strong> conduct<strong>in</strong>grelevant operational research.29


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong> <strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western PacificGoal, Objectives <strong>and</strong> Targets of <strong>the</strong> <strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong>Objective 5Ensure comprehensive coverage of vulnerable, poor<strong>and</strong>/or marg<strong>in</strong>alized populations at high risk ofmalaria with appropriate malaria control measuresIt will be achieved through a number of different means:target groups <strong>and</strong> exist<strong>in</strong>g public health <strong>in</strong>terventions willbe reviewed <strong>and</strong> mapped. Comprehensive new <strong>in</strong>terventionmechanisms, cover<strong>in</strong>g prevention, diagnosis <strong>and</strong> treatment<strong>and</strong> behaviour change communication <strong>and</strong> communitymobilization, will be worked out(based on <strong>in</strong>tegrated primary health care models, whereappropriate) <strong>and</strong> implemented. This <strong>in</strong>cludes <strong>in</strong>termittentpreventive treatment <strong>for</strong> malaria dur<strong>in</strong>g pregnancy (IPTp)through antenatal care services <strong>in</strong> high-transmissionareas. Support<strong>in</strong>g activities will <strong>in</strong>clude <strong>the</strong> <strong>for</strong>mulationof national policies <strong>and</strong> strategies, creat<strong>in</strong>g regionalcooperation frameworks, advocacy, monitor<strong>in</strong>g <strong>and</strong>support <strong>for</strong> relevant operational research (<strong>in</strong>clud<strong>in</strong>g build<strong>in</strong>gcapacity <strong>for</strong> social research). A focal person will beassigned at <strong>the</strong> national programme level to manage <strong>the</strong>seactivities <strong>and</strong> to coord<strong>in</strong>ate capacity-build<strong>in</strong>g.Objective 6Establish <strong>and</strong>/or streng<strong>the</strong>n <strong>the</strong> rout<strong>in</strong>e malaria surveillancesystem (all species) <strong>and</strong> ensure adequateoutbreak response capabilityIt will be achieved through a number of activities:biregional (WHO South-East Asia <strong>and</strong> Western PacificRegions) guidel<strong>in</strong>es on malaria surveillance <strong>and</strong> outbreakpreparedness <strong>and</strong> response will be f<strong>in</strong>alized, adapted tosuit national circumstances <strong>and</strong> endorsed at nationalstakeholder workshops. The national capacity <strong>for</strong>implementation of <strong>the</strong>se guidel<strong>in</strong>es will be streng<strong>the</strong>ned,progress will be monitored, national malaria riskstratifications will be worked out (where necessary)<strong>and</strong> regularly updated, antimalarial drug efficacy <strong>and</strong><strong>in</strong>secticide resistance will be monitored <strong>and</strong> <strong>the</strong> shar<strong>in</strong>g ofmalaria epidemiological <strong>in</strong><strong>for</strong>mation among Member Stateswill be facilitated.30


Objective 7Accelerate malaria (all species) elim<strong>in</strong>ation ef<strong>for</strong>ts <strong>in</strong>participat<strong>in</strong>g countriesIt will be achieved through a number of means: <strong>the</strong> globalmalaria elim<strong>in</strong>ation guidel<strong>in</strong>es will be adapted to <strong>the</strong> AsiaPacific context <strong>and</strong> <strong>the</strong>se will be adopted <strong>and</strong> implementedby participat<strong>in</strong>g countries; strong technical collaborationnetworks will be built; <strong>in</strong>tercountry coord<strong>in</strong>ation <strong>and</strong> harmonizationwill be supported; rigorous elim<strong>in</strong>ation-specificsurveillance will be established; progress will be monitored;<strong>and</strong> needs-based operational research carried out. Thisobjective also <strong>in</strong>corporates <strong>the</strong> conta<strong>in</strong>ment <strong>and</strong> ultimateelim<strong>in</strong>ation of artemis<strong>in</strong><strong>in</strong>-resistant P. falciparum.Detailed activities associated with each of <strong>the</strong>se objectives arepresented <strong>in</strong> <strong>the</strong> logical framework below.Successful implementation of programme activities isexpected to result <strong>in</strong> <strong>the</strong> follow<strong>in</strong>g achievements:(1) Deaths due to malaria (number <strong>and</strong> rate) will decrease byat least 50% by 2015 compared with <strong>the</strong> 2007basel<strong>in</strong>e.(2) Confirmed malaria cases (number <strong>and</strong> rate) will bereduced by at least 50% by 2015 compared with <strong>the</strong> 2007basel<strong>in</strong>e.(3) Percentage of cases due to P. falciparum will bedecreased compared with <strong>the</strong> 2007 basel<strong>in</strong>e.(4) Admitted malaria cases (number <strong>and</strong> rate)will drop by at least 50% by 2015 compared with <strong>the</strong> 2007basel<strong>in</strong>e.(5) <strong>Malaria</strong> test positivity rate (<strong>for</strong> microscopy <strong>and</strong> rapiddiagnostic tests) will be reduced to less than 5% <strong>in</strong> at leastsix countries by 2015.(6) At least seven countries will have achieved <strong>in</strong>terruption ofmalaria transmission <strong>in</strong> targeted areas by 2015.31


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific2010 – 2015Note: [GMI] denotes ‘global malaria <strong>in</strong>dicator’ to be reported at least annually to WHO. All <strong>in</strong>dicators are health <strong>in</strong><strong>for</strong>mation systemor programme <strong>in</strong>dicators unless specified o<strong>the</strong>rwise.<strong>Plan</strong>n<strong>in</strong>g elements Indicators Verification source Assumptions <strong>and</strong> risksOverall regionalgoal:To consolidate <strong>and</strong> build onachievements <strong>in</strong> malariacontrol <strong>in</strong> <strong>the</strong> Region <strong>and</strong>progressively elim<strong>in</strong>atemalaria where possible.1. Deaths due to malaria(number <strong>and</strong> rate) [GMI].<strong>Regional</strong> target: reduction by atleast 50% by 2015compared to 2007 basel<strong>in</strong>e.2. Confirmed malaria cases(number <strong>and</strong> rate) [GMI].<strong>Regional</strong> target: reduction by atleast 50% by 2015 compared to2007 basel<strong>in</strong>e.Member States‘ regularreports to WHONational reports onverification of <strong>in</strong>terruption ofmalaria transmissionGlobal f<strong>in</strong>ancial crisis does notaffect fund<strong>in</strong>g <strong>for</strong> malaria dur<strong>in</strong>gthis period <strong>and</strong> <strong>in</strong>this Region.Political commitment <strong>for</strong> malariacontrol <strong>and</strong> elim<strong>in</strong>ation is <strong>in</strong>creased<strong>and</strong> susta<strong>in</strong>ed.National counterpart resourcesare <strong>in</strong>creased at all levels.3. Cases due to Plasmodiumfalciparum, Plasmodium vivaxor o<strong>the</strong>r malaria parasite spezies(number <strong>and</strong> percentage) [GMI].<strong>Regional</strong> target: decrease <strong>in</strong>percentage of P. falciparumcases compared to 2007basel<strong>in</strong>e.Susta<strong>in</strong>ed <strong>in</strong>terest <strong>in</strong> partnershipsby key stakeholders.Political <strong>and</strong> security situationsdo not <strong>in</strong>terfere with programimplementation.4. Admitted malaria cases(number <strong>and</strong> rate) [GMI].<strong>Regional</strong> target: reduction by atleast 50% by 2015compared to 2008 basel<strong>in</strong>e.5. <strong>Malaria</strong> test positivity rate (<strong>for</strong>microscopy <strong>and</strong> rapiddiagnostic tests) [GMI].<strong>Regional</strong> target: by 2015 atleast six (out of 10) countrieshave a test positivity rateof


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific2010 – 2015Note: [GMI] denotes ‘global malaria <strong>in</strong>dicator’ to be reported at least annually to WHO. All <strong>in</strong>dicators are health <strong>in</strong><strong>for</strong>mation systemor programme <strong>in</strong>dicators unless specified o<strong>the</strong>rwise.<strong>Plan</strong>n<strong>in</strong>g elements Indicators Verification source Assumptions <strong>and</strong> risksObjective 2:Ensure full coverage of<strong>the</strong> population at risk withappropriate vector controlmeasures.1. Percentage of populationat risk covered by long last<strong>in</strong>g<strong>in</strong>secticidal net or <strong>in</strong>secticide-treated bednet distribution[GMI].Annual malaria programmereportsPolicies are applied byMember States.<strong>Malaria</strong> tools cont<strong>in</strong>ue to beeffective.2. Percentage of population atrisk covered by re-treated nets.No shortage of long last<strong>in</strong>g<strong>in</strong>secticidal nets.3. Percentage of population atrisk covered by <strong>in</strong>door residualspray<strong>in</strong>g [GMI].Susta<strong>in</strong>ed <strong>in</strong>terest <strong>in</strong> partnershipsby key stakeholders.4. Percentage of target populationcovered by <strong>in</strong>door residualspray<strong>in</strong>g [GMI].5. Percentage of households atrisk of malaria with at least onelong last<strong>in</strong>g <strong>in</strong>secticidal net or<strong>in</strong>secticide-treatedbednet <strong>and</strong>/or sprayed by<strong>in</strong>door residual spray<strong>in</strong>g <strong>in</strong> <strong>the</strong>last 12 months.Periodic household survey34


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific2010 – 2015<strong>Plan</strong>n<strong>in</strong>g elements Indicators Verification source Assumptions <strong>and</strong> risksObjective 5:Ensure comprehensive coverageof vulnerable, poor<strong>and</strong>/or marg<strong>in</strong>alizedpopulations at high risk ofmalaria with appropriatemalaria control measures.1. Comprehensive <strong>in</strong>terventions<strong>for</strong> vulnerable populations athigh risk of malaria (pregnantwomen, children under fiveyears, ethnic m<strong>in</strong>ority groups,mobile or migrant populations,HIV-positive persons <strong>and</strong>o<strong>the</strong>rs, as applicable) areimplemented accord<strong>in</strong>g topolicy.Annual reports from malariaor o<strong>the</strong>r <strong>in</strong>volved programmesPolitical commitment <strong>for</strong>address<strong>in</strong>g malaria <strong>in</strong>vulnerable populations is <strong>in</strong>creased<strong>and</strong> susta<strong>in</strong>ed.Political <strong>and</strong> security situationsdo not <strong>in</strong>terfere withprogramme implementation.2. Percentage of vulnerablepopulations at high risk ofmalaria covered by long last<strong>in</strong>g<strong>in</strong>secticidal net or <strong>in</strong>secticidetreatedbednet distribution[GMI].Annual reports from malariaor o<strong>the</strong>r <strong>in</strong>volved programmes3. Percentage of pregnantwomen attend<strong>in</strong>g antenatalcare receiv<strong>in</strong>g at least twodoses of <strong>in</strong>termittent preventive<strong>the</strong>rapy [GMI].Note: Only <strong>for</strong> high transmissionareas <strong>in</strong> Pacificcountries.Monthly health <strong>in</strong><strong>for</strong>mationsystems or malariaprogramme reports37


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific2010 – 2015Note: [GMI] denotes ‘global malaria <strong>in</strong>dicator’ to be reported at least annually to WHO. All <strong>in</strong>dicators are health <strong>in</strong><strong>for</strong>mation systemor programme <strong>in</strong>dicators unless specified o<strong>the</strong>rwise.<strong>Plan</strong>n<strong>in</strong>g elements Indicators Verification source Assumptions <strong>and</strong> risksObjective 6:Establish <strong>and</strong>/or streng<strong>the</strong>n<strong>the</strong> rout<strong>in</strong>e malariasurveillance system(all malaria species) <strong>and</strong>ensure adequate outbreakresponse capability.1. Completeness of monthlyhealth facility reports on surveillance<strong>and</strong> logistics [GMI].2. Country has functional system<strong>for</strong> outbreak detection, preparedness<strong>and</strong> timely response.3. The country‘s malaria riskstratification is developed<strong>and</strong> updated at least every fiveyears, based on <strong>the</strong> surveillancedata (confirmed cases).Monthly health <strong>in</strong><strong>for</strong>mationsystems reportsAnnual malaria programmereportsStratification (or re-stratification)reportPolitical commitment all levelsavailable.Human resources can be rapidlymobilized <strong>and</strong> tra<strong>in</strong>ed.Susta<strong>in</strong>ed <strong>in</strong>terest <strong>in</strong> partnershipsby key stakeholders.4. Systematic monitor<strong>in</strong>g ofantimalarial drug efficacy iscarried out at least every two tothree years, accord<strong>in</strong>g to WorldHealth Organization protocol.Annual antimalarial drugefficacy monitor<strong>in</strong>g report5. Systematic monitor<strong>in</strong>g of<strong>in</strong>secticide resistance iscarried out at least every two tothree years, follow<strong>in</strong>gWorld Health Organizationguidel<strong>in</strong>es.Annual malaria programmereports, regional <strong>in</strong>secticideresistance monitor<strong>in</strong>gnetwork reports38


<strong>Regional</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Malaria</strong> <strong>Control</strong> <strong>and</strong><strong>Elim<strong>in</strong>ation</strong> <strong>in</strong> <strong>the</strong> Western Pacific2010 – 2015<strong>Plan</strong>n<strong>in</strong>g elements Indicators Verification source Assumptions <strong>and</strong> risksObjective 7:Accelerate malaria(all species) elim<strong>in</strong>ationef<strong>for</strong>ts <strong>in</strong> participat<strong>in</strong>gcountries.1. Country has an elim<strong>in</strong>ationstrategy <strong>in</strong> l<strong>in</strong>e with regionalguidel<strong>in</strong>es.2. Country has reoriented <strong>the</strong>national malaria control programmetowards anelim<strong>in</strong>ation programme <strong>in</strong> targetedareas.3. Percentage of adm<strong>in</strong>istrativeunits <strong>in</strong> a country with anannual parasite <strong>in</strong>cidence of


ActivitiesResponsibleObjective 1: Streng<strong>the</strong>n malaria programme management based on firm political commitment <strong>and</strong> strong partnerships1.1 Streng<strong>the</strong>n malaria control policies, strategies,guidel<strong>in</strong>es <strong>and</strong> st<strong>and</strong>ard operat<strong>in</strong>g procedures.1.1.1 Review <strong>and</strong> update national malaria policies, strategies,guidel<strong>in</strong>es <strong>and</strong> strategic plans <strong>and</strong> carry outan <strong>in</strong>dependent or jo<strong>in</strong>t review, at leastevery five years.1.1.2 Review <strong>the</strong> malaria programme managementstructure to achieve programme outcomes at alllevels, tak<strong>in</strong>g <strong>in</strong>to account decentralization <strong>and</strong>a programme‘s move to malaria elim<strong>in</strong>ationwhere applicable.1.1.3 Develop a comprehensive human resource capacitydevelopment plan, tak<strong>in</strong>g <strong>in</strong>to account decentralization<strong>and</strong> malaria elim<strong>in</strong>ation, <strong>and</strong> <strong>in</strong>clude it <strong>in</strong> <strong>the</strong> nationalmalaria control <strong>and</strong> elim<strong>in</strong>ation strategic plan.1.1.4 Carry out a monitor<strong>in</strong>g <strong>and</strong> evaluation needsassessment, us<strong>in</strong>g <strong>the</strong> Monitor<strong>in</strong>g <strong>and</strong> EvaluationSystem Streng<strong>the</strong>n<strong>in</strong>g Tool, <strong>and</strong> develop plans <strong>for</strong>streng<strong>the</strong>n<strong>in</strong>g <strong>the</strong> overall national monitor<strong>in</strong>g<strong>and</strong> evaluation framework.1.1.5 Develop <strong>and</strong>/or streng<strong>the</strong>n a rational approach <strong>for</strong><strong>in</strong>tegrat<strong>in</strong>g malaria programme activities <strong>in</strong>to relevan<strong>the</strong>alth programmes at various levels of <strong>the</strong> healthsystem (e.g. Integrated Management of ChildhoodIllnesses).1.1.1 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong>M<strong>in</strong>istry of Health, World Health Organization.1.1.2 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong>M<strong>in</strong>istry of Health.1.1.3 M<strong>in</strong>istry of Health <strong>and</strong> public service departments(World Health Organization to facilitate).1.1.4 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istry ofHealth.1.1.5 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme <strong>and</strong> o<strong>the</strong>r relevant programmes.1.2 Ensure that <strong>the</strong> legal framework is adequate <strong>for</strong>malaria control <strong>and</strong> elim<strong>in</strong>ation.1.2.1 Review exist<strong>in</strong>g legal frameworks regard<strong>in</strong>g publichealth legislation, <strong>in</strong>secticides, medications, etc., <strong>and</strong>amend if required.1.2.2 Ensure adequate implementation of legal systemsregard<strong>in</strong>g public health legislation, <strong>in</strong>secticides,medications, etc., as required, <strong>in</strong>clud<strong>in</strong>g en<strong>for</strong>cementprocesses to address counterfeit<strong>in</strong>g of medic<strong>in</strong>es.1.2.1 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istry ofHealth, o<strong>the</strong>r government sectors, WorldHealth Organization.1.2.2 National government <strong>and</strong> partners, <strong>in</strong>clud<strong>in</strong>g Interpol.1.3 Streng<strong>the</strong>n commitment <strong>for</strong> malaria control <strong>and</strong>elim<strong>in</strong>ation at all levels through advocacy.1.3.1 Document <strong>and</strong> consolidate malaria programmeexperiences, best practices, successes <strong>and</strong> lessonslearnt <strong>for</strong> use <strong>in</strong> advocacy, <strong>and</strong> dissem<strong>in</strong>ate amongstakeholders.1.3.2 Provide regular brief<strong>in</strong>gs to high-level governmentoffcials <strong>and</strong> op<strong>in</strong>ion leaders.1.3.3 Implement appropriate communication strategiestarget<strong>in</strong>g all partners of malaria programmesat all levels with<strong>in</strong> each country.1.3.4 Promote <strong>the</strong> malaria agenda through high-levelpolitical regional <strong>for</strong>ums.401.3.1 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istry ofHealth, World Health Organization <strong>and</strong> partners.1.3.2 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istry ofHealth, o<strong>the</strong>r government sectors.1.3.3 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istry ofHealth, partners.1.3.4 World Health Organization, United Nations SpecialEnvoy <strong>and</strong> partners.


ActivitiesResponsibleObjective 1: Streng<strong>the</strong>n malaria programme management based on firm political commitment <strong>and</strong> strong partnerships1.4 Identify fund<strong>in</strong>g sources <strong>and</strong> secure adequatef<strong>in</strong>ancial support.1.4.1 Have a costed national malaria strategy <strong>in</strong> <strong>the</strong> short<strong>and</strong>medium-term.1.4.2 Identify fund<strong>in</strong>g gaps.1.4.3 Secure flexible, consistent <strong>and</strong> adequate fund<strong>in</strong>gfrom <strong>in</strong>ternal <strong>and</strong> external sources to ensuresusta<strong>in</strong>ability of programmatic ef<strong>for</strong>ts.1.4.4 Support countries to secure adequate fund<strong>in</strong>g,<strong>for</strong> example, through technical support <strong>for</strong> proposalwrit<strong>in</strong>g.1.4.5 Incorporate malaria as a key agenda item <strong>in</strong> o<strong>the</strong>rdevelopment <strong>in</strong>itiatives.1.5 Streng<strong>the</strong>n technical <strong>and</strong> adm<strong>in</strong>istrativemanagement capacity.1.5.1 Streng<strong>the</strong>n human resources (based on <strong>the</strong> humanresource plan, see activity 1.1.3 through recruitment,retention, professional development, tra<strong>in</strong><strong>in</strong>g,super vision <strong>and</strong> o<strong>the</strong>r methods to improve staffcapacity [Special emphasis on capacity developmentwill be required <strong>in</strong> countries adopt<strong>in</strong>g a malariaelim<strong>in</strong>ation approach].1.5.2 Ensure adequate <strong>in</strong>frastructure <strong>and</strong> streng<strong>the</strong>nlogistics capability to support malaria programmeoperations.1.5.3 Streng<strong>the</strong>n f<strong>in</strong>ancial management.1.6 Streng<strong>the</strong>n country <strong>and</strong> <strong>in</strong>ternational stakeholdercoord<strong>in</strong>ation.1.6.1 Streng<strong>the</strong>n national coord<strong>in</strong>ation of malariaprogramme activities.1.6.2 Promote <strong>in</strong>tegration of malaria control <strong>and</strong> elim<strong>in</strong>ationwith o<strong>the</strong>r public health programmes, maximiz<strong>in</strong>gsynergies where possible.1.6.3 Develop mechanisms <strong>for</strong> <strong>in</strong>tersectoral cooperation,<strong>and</strong> promote <strong>in</strong>tegration of malaria control, <strong>in</strong>volv<strong>in</strong>g<strong>the</strong> private sector <strong>and</strong> nongovernmentalorganizations.1.4.1 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, o<strong>the</strong>r relevant government <strong>and</strong>nongovernment sectors.1.4.2 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istry of Health.1.4.3 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, o<strong>the</strong>r relevant government <strong>and</strong>nongovernment sectors.1.4.4 World Health Organization <strong>and</strong> o<strong>the</strong>r partners.1.4.5 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, o<strong>the</strong>r relevant government <strong>and</strong>nongovernment sectors.1.5.1 M<strong>in</strong>istry of Health <strong>and</strong> National <strong>Malaria</strong> <strong>Control</strong>Programme, public service departments <strong>and</strong> humanresource specialists <strong>in</strong> <strong>the</strong> health sector.1.5.2 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, partners.1.5.3 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, M<strong>in</strong>istry of F<strong>in</strong>ance.1.6.1 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, World Health Organization.1.6.2 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istryof Health <strong>and</strong> relevant public health programmes.1.6.3 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, relevant sectors <strong>and</strong> partners, World HealthOrganization.1.6.4 Incorporate malaria <strong>in</strong>to environmental impact assessments <strong>for</strong> all major development projects, <strong>and</strong> workclosely with multisectoral partners to prevent<strong>the</strong> development of new malaria transmission foci.1.6.5 Promote <strong>and</strong> facilitate regional, sub-regional <strong>and</strong><strong>in</strong>ter-regional cooperation <strong>and</strong> coord<strong>in</strong>ation ofmalaria control <strong>and</strong> elim<strong>in</strong>ation programmes.1.6.4 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health.1.6.5 World Health Organization, Mekong <strong>Malaria</strong> Program, RollBack <strong>Malaria</strong> Partnership, Association of Sou<strong>the</strong>ast AsianNations, Asia-Pacific <strong>Malaria</strong> <strong>Elim<strong>in</strong>ation</strong> Network, <strong>and</strong>o<strong>the</strong>r regional <strong>and</strong> sub-regional networks.41


ActivitiesResponsibleObjective 1: Streng<strong>the</strong>n malaria programme management based on firm political commitment <strong>and</strong> strong partnerships1.7 Streng<strong>the</strong>n key technical support networks.1.71 Promote dissem<strong>in</strong>ation, adoption <strong>and</strong> implementationof best practices through technical networks(see activity 1.3.1).1.72 Develop annual workplans <strong>and</strong> susta<strong>in</strong>able f<strong>in</strong>anc<strong>in</strong>gmechanism <strong>for</strong> implementation of designated activitiesat World Health Organization collaborat<strong>in</strong>g centres.1.7.3 Collaborate with exist<strong>in</strong>g <strong>and</strong> emerg<strong>in</strong>g regional <strong>and</strong>sub-regional malaria networks (e.g. ACT<strong>Malaria</strong>,Asia Vivax Network, Asia-Pacific <strong>Malaria</strong> <strong>Elim<strong>in</strong>ation</strong>Network, SEAMEO TROPMED).1.7.1 World Health Organization <strong>and</strong> partners.1.7.2 World Health Organization, Member States,collabora t<strong>in</strong>g centres <strong>and</strong> partners.1.7.3 Member States, World Health Organization <strong>and</strong>partners.1.8 Streng<strong>the</strong>n programmatic monitor<strong>in</strong>g <strong>and</strong> evaluation.1.8.1 Improve <strong>and</strong> implement monitor<strong>in</strong>g <strong>and</strong> evaluation<strong>for</strong> <strong>the</strong> malaria programme based on <strong>the</strong> nationalmonitor<strong>in</strong>g <strong>and</strong> evaluation plan, through <strong>the</strong> rout<strong>in</strong>ehealth <strong>in</strong><strong>for</strong>mation system <strong>and</strong> o<strong>the</strong>r methods asappropriate (<strong>in</strong>clud<strong>in</strong>g periodic malaria <strong>in</strong>dicatorsurveys, sent<strong>in</strong>elsite surveillance).1.8.2 Prepare annual reports <strong>for</strong> <strong>the</strong> malaria programme<strong>and</strong> submit <strong>the</strong>m to key stakeholders <strong>in</strong>clud<strong>in</strong>g WorldHealth Organization.1.8.3 Harmonize regional malaria m<strong>in</strong>imum data-sets.1.8.4 Conduct regular malaria programme reviews.1.9 Streng<strong>the</strong>n cross-border collaboration.1.9.1 Develop <strong>and</strong> implement cross-border malaria actionplans, <strong>and</strong> synergize with exist<strong>in</strong>g cross-bordercollaborations, both <strong>in</strong>ternationally <strong>and</strong> nationally(<strong>in</strong>terprov<strong>in</strong>cial collaboration).1.9.2 Support <strong>in</strong>ternational <strong>and</strong> national border meet<strong>in</strong>gs atdistrict, prov<strong>in</strong>cial <strong>and</strong> central levels.1.9.3 Monitor progress based on identified meet<strong>in</strong>grecommendations <strong>and</strong> cross-border actions.1.8.1 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istryof Health <strong>and</strong> partners.1.8.2 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health.1.8.3 World Health Organization to facilitate.1.8.4 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, World Health Organization <strong>and</strong> partners.1.9.1 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, M<strong>in</strong>istry of Foreign Affairs, relevantgovernment sectors <strong>and</strong> partners.1.9.2 Member States, World Health Organization <strong>and</strong>partners.1.9.3 World Health Organization, National <strong>Malaria</strong> <strong>Control</strong>Programme <strong>and</strong> M<strong>in</strong>istry of Health.1.10 Coord<strong>in</strong>ate operational research <strong>and</strong> set priorities.1.10.1 Periodically identify regional, sub-regional <strong>and</strong> nationalresearch priorities (with special attention to socialscience gaps <strong>in</strong>clud<strong>in</strong>g gender).1.10.2 Support regular technical reviews of national researchf<strong>in</strong>d<strong>in</strong>gs <strong>and</strong> update national plans, policies<strong>and</strong> research priorities accord<strong>in</strong>gly.1.10.3 Promote <strong>the</strong> conduct of jo<strong>in</strong>t operational researchbetween <strong>the</strong> malaria programme <strong>and</strong> academiato fill programmatic gaps.1.10.4 Support advocacy <strong>for</strong> bi-regional, regional <strong>and</strong>sub-regional malaria research <strong>in</strong>itiatives.421.10.1 World Health Organization <strong>and</strong> partners (regional),National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health <strong>and</strong> partners (national).1.10.2 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health <strong>and</strong> partners.1.10.3 World Health Organization, National <strong>Malaria</strong> <strong>Control</strong>Programme, M<strong>in</strong>istry of Health <strong>and</strong> partners.1.10.4 World Health Organization <strong>and</strong> partners.


ActivitiesResponsibleObjective 2: Ensure full coverage of <strong>the</strong> population at risk with appropriate vector control measures.2.1 Achieve <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong> universal coverage of <strong>the</strong>at-risk population (static <strong>and</strong> mobile) with free longlast<strong>in</strong>g impregnated materials, e.g. long last<strong>in</strong>g<strong>in</strong>secticidal nets, hammock nets or conventionalnets treated or re-treated with long last<strong>in</strong>g <strong>in</strong>secticideto achieve effective vector control.2.1 National <strong>Malaria</strong> <strong>Control</strong> Programme, World HealthOrganization Pesticide Evaluation Scheme<strong>and</strong> qualified quality assurance facilities, partners.2.1.1 Develop st<strong>and</strong>ard operat<strong>in</strong>g procedures.2.1.2 Conduct periodic plann<strong>in</strong>g <strong>and</strong> quantification of needs.2.1.3 Procure commodities.2.1.4 Develop human resources as necessary.2.1.5 Conduct quality assurance <strong>for</strong> commodities<strong>in</strong>clud<strong>in</strong>g tenacity <strong>and</strong> burst<strong>in</strong>g strength <strong>for</strong> nets.2.1.6 Develop <strong>and</strong> implement distribution <strong>and</strong> re-treatmentplan (macro <strong>and</strong> micro).2.1.5 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> o<strong>the</strong>rstakeholders. World Health Organization PesticideEvaluation Scheme to facilitate.2.1.7 Monitor quality <strong>and</strong> coverage of service delivery <strong>and</strong>utilization of nets.2.2 Develop <strong>and</strong> periodically review quality assurance<strong>for</strong> vector control products us<strong>in</strong>g st<strong>and</strong>ard protocols(World Health Organization Pesticide EvaluationScheme, Global <strong>Malaria</strong> Programme), <strong>and</strong> identify<strong>and</strong> certify quality assurance laboratories.2.3 Implement high quality preventive <strong>and</strong>/orresponsive <strong>in</strong>door residual spray<strong>in</strong>g whereappropriate, based on vector behaviour <strong>and</strong>malaria risk stratification (see 6.5).2.2 World Health Organization Global <strong>Malaria</strong> Programme,World Health Organization Pesticide Evaluation Scheme.2.3 National <strong>Malaria</strong> <strong>Control</strong> Programme, supported byWorld Health Organization <strong>and</strong> technical partners.2.3.1 Develop regional guidel<strong>in</strong>es on <strong>the</strong> use of <strong>in</strong>doorresidual spray<strong>in</strong>g <strong>and</strong> <strong>the</strong> comb<strong>in</strong>ed use of longlast<strong>in</strong>g <strong>in</strong>secticidal nets <strong>and</strong> <strong>in</strong>door residual spray<strong>in</strong>g.2.3.2 Develop st<strong>and</strong>ard operat<strong>in</strong>g procedures.2.3.3 Conduct geographical reconnaissance, plann<strong>in</strong>g<strong>and</strong> quantification of needs.2.3.4 Procure <strong>in</strong>secticides <strong>and</strong> equipment.2.3.5 Develop human resources as necessary.2.3.6 Conduct quality assurance <strong>for</strong> <strong>in</strong>secticides<strong>and</strong> equipment.2.3.7 Implement <strong>in</strong>door residual spray<strong>in</strong>g as appropriate.2.3.8 Monitor quality <strong>and</strong> coverage of <strong>in</strong>doorresidual spray<strong>in</strong>g.43


ActivitiesResponsibleObjective 2: Ensure full coverage of <strong>the</strong> population at risk with appropriate vector control measures.2.4 Streng<strong>the</strong>n management <strong>and</strong> judicious use ofpublic health <strong>in</strong>secticides.2.4.1 Adhere to World Health Organization Pesticide EvaluationScheme recommendations dur<strong>in</strong>g procurementof <strong>in</strong>secticides.2.4 National <strong>Malaria</strong> <strong>Control</strong> Programme, supportedby World Health Organization (<strong>in</strong>clud<strong>in</strong>g WorldHealth Organization Pesticide Evaluation Scheme),Food <strong>and</strong> Agriculture Organization <strong>and</strong> technicalpartners.2.4.2 Develop <strong>and</strong> implement guidel<strong>in</strong>es on management<strong>and</strong> judicious use of public health <strong>in</strong>secticides,<strong>in</strong>clud<strong>in</strong>g annual report<strong>in</strong>g of <strong>in</strong>secticide usage(to <strong>the</strong> World Health Organization) <strong>and</strong> safe disposalof expired <strong>in</strong>secticides.2.5 Introduce Integrated Vector Management whereappropriate.2.5.1 Conduct vector control needs assessment.2.5 National <strong>Malaria</strong> <strong>Control</strong> Programme, supported byWorld Health Organization (<strong>in</strong>clud<strong>in</strong>g NeglectedTropical Diseases <strong>and</strong> Vector Ecology <strong>and</strong> Managementunits) <strong>and</strong> technical partners.2.5.2 Develop <strong>and</strong> implement regional <strong>and</strong> nationalIntegrated Vector Management strategic planwhere appropriate.2.5.3 Build national capacity to implement Integrated VectorManagement pr<strong>in</strong>ciples <strong>and</strong> practices.2.6 Conduct needs-based operational research onvector control <strong>and</strong> personal protection.2.6.1 Develop <strong>in</strong>novative <strong>and</strong> appropriate vector control <strong>and</strong>personal protection measures with special emphasison high-risk groups <strong>and</strong> high-risk behaviour(epidemiological, entomological <strong>and</strong> social research).2.6.2 Develop improved quality assurance assay methodologies<strong>for</strong> long-last<strong>in</strong>g <strong>in</strong>secticidal nets <strong>and</strong> residual<strong>in</strong>secticides.2.6 National research <strong>in</strong>stitutions <strong>and</strong> groups (<strong>in</strong>clud<strong>in</strong>gNational <strong>Malaria</strong> <strong>Control</strong> Programme) <strong>and</strong> WorldHealth Organization at <strong>the</strong> global level (TropicalDisease Research, Global <strong>Malaria</strong> Programme,World Health Organization Pesticide EvaluationScheme) <strong>and</strong> at <strong>the</strong> Western Pacific <strong>Regional</strong> Office(Healthy Sett<strong>in</strong>gs <strong>and</strong> Environment, Health SystemsDevelopment, <strong>Malaria</strong> <strong>and</strong> o<strong>the</strong>r Vector-borne <strong>and</strong>Parasitic Diseases).2.6.3 Investigate <strong>the</strong> additional impact <strong>and</strong> cost-effectiveness of comb<strong>in</strong><strong>in</strong>g long-last<strong>in</strong>g <strong>in</strong>secticidal nets <strong>and</strong><strong>in</strong>door residual spray<strong>in</strong>g <strong>in</strong>terventions.2.6.4 Conduct environmental <strong>and</strong> climate impact studies onmalaria transmission <strong>and</strong> <strong>in</strong>vestigate <strong>the</strong> role of malariavectors <strong>in</strong> development projects.2.6.5 Develop an approach <strong>and</strong> mechanisms <strong>for</strong> deal<strong>in</strong>g withold long last<strong>in</strong>g <strong>in</strong>secticidal nets.44


ActivitiesResponsibleObjective 3: Maximize utilization of malaria services (through appropriate <strong>in</strong><strong>for</strong>mation, education <strong>and</strong> communication <strong>and</strong>/orbehaviour change communication) <strong>and</strong> dramatically streng<strong>the</strong>n community mobilization ef<strong>for</strong>ts.3.1 Implement comprehensive health promotion <strong>and</strong>behaviour change communication campaigns.3.1.1 Develop <strong>and</strong>/or update <strong>the</strong> policy or strategy <strong>for</strong> healthpromotion <strong>and</strong> behaviour change communication.3.1.2 Regularly assess behaviour change communicationmethodology <strong>and</strong> approaches <strong>and</strong> revise asappropriate.3.1 National <strong>Malaria</strong> <strong>Control</strong> Programme, centres <strong>for</strong>health education, o<strong>the</strong>r government programmes<strong>and</strong> departments, nongovernmental organizations<strong>and</strong> civil society, supported by World HealthOrganization, United Nations Children‘s Fund<strong>and</strong> o<strong>the</strong>r partners.3.1.3 Streng<strong>the</strong>n capacity <strong>in</strong> relation to behaviour changecommunication.3.1.4 Coord<strong>in</strong>ate behaviour change communication activitieswith relevant partners <strong>and</strong> with o<strong>the</strong>r healthprogrammes.3.1.5 Implement targeted behaviour change communicationcampaigns <strong>and</strong>/or activities <strong>for</strong> key aspects of <strong>the</strong>malaria programme, <strong>in</strong>clud<strong>in</strong>g:Key messages on diagnosis <strong>and</strong> treatment <strong>for</strong>providers <strong>and</strong> <strong>the</strong> population at risk:- diagnosis be<strong>for</strong>e treatment;- early diagnosis <strong>and</strong> treatment;- correct medic<strong>in</strong>es, dosages <strong>and</strong> compliance;- awareness about counterfeit medic<strong>in</strong>es.Key messages on vector control <strong>for</strong> <strong>the</strong> populationat risk:- importance of habitual use of long last<strong>in</strong>g<strong>in</strong>secticidal net or conventional <strong>in</strong>secticide-treated net;- regular <strong>in</strong>secticide re-treatment of conventionalmosquito nets;- importance of compliance with <strong>in</strong>door residualspray<strong>in</strong>g.3.2 Implement comprehensive communitymobilization activities.3.2.1 Engage communities to ensure ownership <strong>and</strong>participation <strong>in</strong> comprehensive malaria control<strong>and</strong> elim<strong>in</strong>ation activities.3.2 National <strong>Malaria</strong> <strong>Control</strong> Programme, nongovernmentalorganizations, partners, <strong>and</strong> governmentat all levels.3.2.2 Engage local government units <strong>and</strong> o<strong>the</strong>r keystake holders to ensure smooth implementation<strong>and</strong> susta<strong>in</strong>ability of <strong>the</strong> malaria programme.3.3 Carry out periodic evaluations to assess <strong>the</strong>impact of <strong>in</strong><strong>for</strong>mation, education <strong>and</strong> communicationmaterials <strong>and</strong> behaviour change communi-cation on <strong>the</strong> utilization of malaria controlservices.3.4 Conduct needs-based operational research(e.g. community preferences <strong>and</strong> acceptability ofvarious vector control measures).3.3 National <strong>Malaria</strong> <strong>Control</strong> Programme <strong>and</strong> M<strong>in</strong>istryof Health, <strong>and</strong> partners.3.4 National <strong>Malaria</strong> <strong>Control</strong> Programme, researchorganizations <strong>and</strong> technical partners.45


ActivitiesResponsibleObjective 4: Ensure access <strong>for</strong> all to early diagnosis <strong>and</strong> af<strong>for</strong>dable, safe, effective <strong>and</strong> prompt antimalarial comb<strong>in</strong>ationtreatments through active public <strong>and</strong> private sector <strong>in</strong>itiatives.4.1 Ensure country-wide coverage with qualityparasite-based diagnosis (microscopy <strong>and</strong> malariarapid diagnostic tests), <strong>in</strong>clud<strong>in</strong>g <strong>for</strong> P. vivax.4.1.1 Ensure adequate coverage of quality diagnosticservices at health facility <strong>and</strong> community levels,as part of <strong>the</strong> national health system.4.1.2 Develop policies <strong>and</strong> implement quality assuranceof diagnostics (microscopy <strong>and</strong> rapid diagnostic tests).4.1.3 Exp<strong>and</strong> <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong> regional quality assurance <strong>in</strong>malaria diagnostics (<strong>in</strong>clud<strong>in</strong>g management ofslide bank).4.2 Ensure un<strong>in</strong>terrupted availability of antimalarialmedic<strong>in</strong>es <strong>and</strong> diagnostics at all publichealth facilities serv<strong>in</strong>g populations at risk, aswell as at community level where appropriate<strong>and</strong> <strong>in</strong> <strong>the</strong> private sector where possible.4.2.1 Develop <strong>and</strong>/or update procurement <strong>and</strong> supplymanagement guidel<strong>in</strong>es.4.2.2 Support timely procurement of quality diagnostics<strong>and</strong> antimalarials, <strong>in</strong>clud<strong>in</strong>g quantification.4.2.3 Improve storage, regular stock management <strong>and</strong>distribution of diagnostic <strong>and</strong> antimalarial suppliesat all levels.4.2.4 Improve <strong>the</strong> storage of rapid diagnostic tests <strong>and</strong>artemis<strong>in</strong><strong>in</strong>-based comb<strong>in</strong>ation <strong>the</strong>rapy at <strong>the</strong>peripheral level where electricity is not available, e.g.through <strong>the</strong> use of cooler boxes, <strong>and</strong> monitor<strong>the</strong>ir implementation.4.1.1 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme.4.1.2 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme, World Health Organization.4.1.3 World Health Organization, Foundation <strong>for</strong> InnovativeNew Diagnostics, Research Institute of TropicalMedic<strong>in</strong>e of <strong>the</strong> Philipp<strong>in</strong>es, Pasteur InstituteCambodia <strong>and</strong> o<strong>the</strong>r laboratories, Asian CollaborativeTra<strong>in</strong><strong>in</strong>g Network <strong>for</strong> <strong>Malaria</strong>.4.2.1 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong> Programme,Food <strong>and</strong> Drug Adm<strong>in</strong>istration, WorldHealth Organization.4.2.2 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme, World Health Organization, UnitedNations Children’s Fund.4.2.3 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme, central medical stores, hospitals.4.2.4 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme.4.3 Ensure access to safe <strong>and</strong> effective antimalarialcomb<strong>in</strong>ation treatment <strong>for</strong> all populationsat risk, <strong>in</strong>clud<strong>in</strong>g <strong>for</strong> P. vivax.4.3.1 Regularly review <strong>and</strong>, if necessary, update nationalmalaria treatment guidel<strong>in</strong>es based onavailable evidence (see activity 6.6), <strong>in</strong> <strong>the</strong> contextof elim<strong>in</strong>ation where appropriate.4.3.2 Provide antimalarial treatment accord<strong>in</strong>g to nationaltreatment guidel<strong>in</strong>es.4.3.3 Incorporate community-based treatment target<strong>in</strong>ghard-to-reach populations (<strong>in</strong>clud<strong>in</strong>g ethnic m<strong>in</strong>orities)<strong>in</strong>to national health systems (<strong>in</strong>clud<strong>in</strong>g f<strong>in</strong>anc<strong>in</strong>g).4.3.1 M<strong>in</strong>istry of Health <strong>and</strong> National <strong>Malaria</strong> <strong>Control</strong>Programme, supported by World Health Organization.4.3.2 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme.4.3.3 M<strong>in</strong>istry of Health.46


ActivitiesResponsibleObjective 4: Ensure access <strong>for</strong> all to early diagnosis <strong>and</strong> af<strong>for</strong>dable, safe, effective <strong>and</strong> prompt antimalarial comb<strong>in</strong>ationtreatments through active public <strong>and</strong> private sector <strong>in</strong>itiatives.4.3.4 Develop appropriate tra<strong>in</strong><strong>in</strong>g <strong>and</strong> <strong>in</strong><strong>for</strong>mation, education<strong>and</strong> communication materials to improve <strong>the</strong> acceptability<strong>and</strong> use of artemis<strong>in</strong><strong>in</strong>-derivative suppositories<strong>for</strong> pre-referral treatment of suspected severe malaria.4.3.5 Develop <strong>and</strong> implement appropriate strategies toaddress G6PD deficiency <strong>in</strong> P. vivax radicalcure treatment.4.3.6 Establish <strong>and</strong> maa<strong>in</strong>ta<strong>in</strong> pharmacovigilance system.4.3.7 Conduct regular quality monitor<strong>in</strong>g of antimalarialmedic<strong>in</strong>es (public <strong>and</strong> private sector).4.3.8 Support appropriate actions <strong>in</strong> case subst<strong>and</strong>ard orcounterfeit antimalarials are found, <strong>in</strong>clud<strong>in</strong>gen<strong>for</strong>cement of legislation.4.3.9 Participate <strong>in</strong> <strong>in</strong>ter-country <strong>and</strong> regional coord<strong>in</strong>ationef<strong>for</strong>ts on case management issues.4.4 Build awareness <strong>and</strong> ensure commitment at alllevels to prevent development <strong>and</strong> spreadof artemis<strong>in</strong><strong>in</strong> resistance.4.4.1 Promote rational use of artemis<strong>in</strong><strong>in</strong>-based comb<strong>in</strong>ation<strong>the</strong>rapy <strong>for</strong> uncomplicated malaria among careproviders <strong>and</strong> users.4.4.2 Withdraw oral artemis<strong>in</strong><strong>in</strong> mono<strong>the</strong>rapy from public<strong>and</strong> private sector <strong>and</strong> en<strong>for</strong>ce this.4.3.4 National <strong>Malaria</strong> <strong>Control</strong> Programme.4.3.5 National <strong>Malaria</strong> <strong>Control</strong> Programme, hospitaldepartment, M<strong>in</strong>istry of Health.4.3.6 Drug Regulatory Authority <strong>and</strong> M<strong>in</strong>istry of Health.4.3.7 Drug Regulatory Authority, National <strong>Malaria</strong> <strong>Control</strong>Programme, partners.4.3.8 Drug Regulatory Authority, National <strong>Malaria</strong> <strong>Control</strong>Programme, Police, Customs, Interpol, World HealthOrganization.4.3.9 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istry ofHealth, World Health Organization, partners<strong>and</strong> networks.4.4.1 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong> Programme,Drug Regulatory Authority, tra<strong>in</strong><strong>in</strong>g <strong>in</strong>stitutions,partners.4.4.2 M<strong>in</strong>istry of Health, Drug Regulatory Authority.4.5 Engage <strong>the</strong> private sector <strong>in</strong> effective diagnosis,treatment <strong>and</strong> report<strong>in</strong>g of malaria.4.5.1 Develop regional <strong>and</strong> national policies to engage with<strong>the</strong> private sector <strong>in</strong> malaria diagnosis, treatment<strong>and</strong> report<strong>in</strong>g (<strong>in</strong>clud<strong>in</strong>g task <strong>for</strong>ces, countrypilots <strong>and</strong> evaluations).4.5.2 Evaluate <strong>and</strong> document exist<strong>in</strong>g private sector<strong>in</strong>itiatives.4.5.1 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong> Programme,Drug Regulatory Authority, hospital department, medical<strong>and</strong> pharmacists associations, supported by World HealthOrganization <strong>and</strong> technical partners.4.5.2 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong> Programme,World Health Organization, medical <strong>and</strong> pharmacistsassociations.4.5.3 Establish <strong>and</strong> exp<strong>and</strong> engagement of <strong>the</strong> privatesector <strong>in</strong> malaria diagnosis <strong>and</strong> treatment, whereappropriate.4.5.3 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong> Programme,medical <strong>and</strong> pharmacists associations,medical registration boards, partners.4.5.4 Coord<strong>in</strong>ate with <strong>the</strong> Af<strong>for</strong>dable Medic<strong>in</strong>es Facilitymalaria (AMFm) to ensure that treatment will bel<strong>in</strong>ked to parasite-based diagnosis.4.5.4 National <strong>Malaria</strong> <strong>Control</strong> Programme, Drug RegulatoryAuthority, M<strong>in</strong>istry of Health.47


ActivitiesResponsibleObjective 4: Ensure access <strong>for</strong> all to early diagnosis <strong>and</strong> af<strong>for</strong>dable, safe, effective <strong>and</strong> prompt antimalarial comb<strong>in</strong>ationtreatments through active public <strong>and</strong> private sector <strong>in</strong>itiatives.4.6 Build <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong> human <strong>and</strong> health systemscapacity at all levels <strong>for</strong> adequate managementof malaria <strong>and</strong> o<strong>the</strong>r febrile conditions(differential diagnosis).4.6.1 Conduct tra<strong>in</strong><strong>in</strong>g <strong>and</strong> regular refresher tra<strong>in</strong><strong>in</strong>g,cover<strong>in</strong>g parasite-based diagnosis, microscoperepair <strong>and</strong> ma<strong>in</strong>tenance, supplies quantification,procurement <strong>and</strong> supply management, treatmentof uncomplicated <strong>and</strong> severe malaria, etc.4.6.2 Conduct supportive supervision dur<strong>in</strong>g <strong>in</strong>tegratedsupervisory visits, <strong>in</strong>clud<strong>in</strong>g follow-up on tra<strong>in</strong><strong>in</strong>geffectiveness.4.6.3 Exp<strong>and</strong> differential diagnostic <strong>and</strong> treatmentcapacity of febrile illnesses <strong>and</strong> ensure adequatesupplies <strong>and</strong> equipment at health facility <strong>and</strong>community levels.4.6.4 Develop <strong>and</strong> share tra<strong>in</strong><strong>in</strong>g modules.4.6.1 National <strong>Malaria</strong> <strong>Control</strong> Programme, medical tra<strong>in</strong><strong>in</strong>g<strong>in</strong>stitutions.4.6.2 National <strong>Malaria</strong> <strong>Control</strong> Programme,M<strong>in</strong>istry of Health.4.6.3 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istryof Health, Centre <strong>for</strong> Disease <strong>Control</strong>, Maternal <strong>and</strong>Child Health.4.6.4 National <strong>Malaria</strong> <strong>Control</strong> Programme, ACT<strong>Malaria</strong>,World Health Organization, tra<strong>in</strong><strong>in</strong>g <strong>in</strong>stitutions.4.7 Ensure adequate monitor<strong>in</strong>g <strong>and</strong> evaluation ofdiagnostic <strong>and</strong> treatment coverage <strong>and</strong> practices<strong>and</strong> supply management at health facility<strong>and</strong> community levels.4.7.1 Update monitor<strong>in</strong>g <strong>and</strong> evaluation guidel<strong>in</strong>es,<strong>in</strong>clud<strong>in</strong>g those <strong>for</strong> <strong>the</strong> community level.4.7.2 Streng<strong>the</strong>n rout<strong>in</strong>e monitor<strong>in</strong>g of malaria treatmentquality <strong>and</strong> diagnostic practices, e.g. through <strong>the</strong> useof a malaria patient card.4.7.3 Streng<strong>the</strong>n rout<strong>in</strong>e monitor<strong>in</strong>g of <strong>the</strong> management ofof antimalarial medic<strong>in</strong>es <strong>and</strong> diagnostics, <strong>in</strong>clud<strong>in</strong>gat <strong>the</strong> community level.4.7.4 Conduct surveys to evaluate diagnostic <strong>and</strong> treatmentpractices <strong>and</strong> availability of supplies <strong>and</strong> equipment.4.7.1 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istryof Health, World Health Organization, partners.4.7.2 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istryof Health.4.7.3 National <strong>Malaria</strong> <strong>Control</strong> Programme, central medicalstore, drug regulatory authority, M<strong>in</strong>istry of Health.4.7.4 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istryof Health, <strong>in</strong>stitutes of public health, World HealthOrganization, partners.48


ActivitiesResponsibleObjective 4: Ensure access <strong>for</strong> all to early diagnosis <strong>and</strong> af<strong>for</strong>dable, safe, effective <strong>and</strong> prompt antimalarial comb<strong>in</strong>ationtreatments through active public <strong>and</strong> private sector <strong>in</strong>itiatives.4.8 Conduct relevant operational research related tomalaria diagnosis <strong>and</strong> treatment, <strong>in</strong>clud<strong>in</strong>g:4.8.1 Develop a simple <strong>and</strong> rapid test <strong>for</strong> G6PD deficiency.4.8 National <strong>Malaria</strong> <strong>Control</strong> Programme, M<strong>in</strong>istry ofHealth, research <strong>in</strong>stitutions, national <strong>and</strong> <strong>in</strong>ternationalpartners <strong>in</strong>clud<strong>in</strong>g World Health Organization.4.8.2 Conduct surveys of G6PD deficiency <strong>and</strong> mapf<strong>in</strong>d<strong>in</strong>gs.4.8.3 Develop <strong>and</strong> execute a series of research studies(cl<strong>in</strong>ical <strong>and</strong> laboratory) lead<strong>in</strong>g to <strong>the</strong> safest possibleapplication of primaqu<strong>in</strong>e aga<strong>in</strong>st P. vivax malaria, bycountry, <strong>in</strong>clud<strong>in</strong>g short-course treatment.4.8.4 Evaluate <strong>the</strong>rapies <strong>for</strong> radical cure that may be appliedto ei<strong>the</strong>r P. falciparum or P. vivax malaria or both.4.8.5 Explore improved adherence to national treatmentguidel<strong>in</strong>es, <strong>in</strong>clud<strong>in</strong>g those <strong>for</strong> P. vivax (packag<strong>in</strong>g,<strong>for</strong>mulation, supervised treatment, tra<strong>in</strong><strong>in</strong>g,<strong>in</strong><strong>for</strong>mation, education <strong>and</strong> communication <strong>and</strong>behaviour change communication).4.8.6 Assess <strong>the</strong> feasibility <strong>and</strong> acceptability of use ofprereferral artemis<strong>in</strong><strong>in</strong>-derivative suppositories <strong>for</strong>severe malaria.4.8.7 Evaluate <strong>and</strong> document experiences with communitybasedmalaria diagnosis <strong>and</strong> treatment <strong>in</strong> countriesacross <strong>the</strong> Region.4.8.8 Assess local causes of non-malaria febrile illnesses <strong>for</strong>development of case management algorithm.4.8.9 Complete development <strong>and</strong> validation of <strong>the</strong> coolerbox system <strong>for</strong> rapid diagnostic tests <strong>and</strong>artemis<strong>in</strong><strong>in</strong>-based comb<strong>in</strong>ation <strong>the</strong>rapy storage.49


ActivitiesResponsibleObjective 5: Ensure comprehensive coverage of vulnerable, poor <strong>and</strong>/or marg<strong>in</strong>alized populations at high risk ofmalaria with appropriate malaria control measures.5.1 Identify <strong>and</strong> characterize target groups, <strong>the</strong>irhealth problems <strong>and</strong> <strong>the</strong>ir basic health behaviours.Vulnerable groups who live <strong>in</strong> or move <strong>in</strong>to malaria riskareas <strong>in</strong>clude:• pregnant women;• children under five years;• ethnic m<strong>in</strong>ority groups;• mobile <strong>and</strong>/or migrant populations, <strong>in</strong>clud<strong>in</strong>gm<strong>in</strong>ers <strong>and</strong> <strong>for</strong>est goers;• people liv<strong>in</strong>g with HIV/AIDS;• neglected, poor <strong>and</strong> marg<strong>in</strong>alized groups;• military;• prisoners;• refugees;• isl<strong>and</strong> populations;• o<strong>the</strong>rs where applicable.5.1 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme, o<strong>the</strong>r programmes <strong>and</strong> sectors,partners <strong>in</strong>clud<strong>in</strong>g World Health Organization.5.2 Review <strong>and</strong> map exist<strong>in</strong>g public health<strong>in</strong>terventions <strong>for</strong> <strong>the</strong>se groups, exam<strong>in</strong><strong>in</strong>g:• stakeholders <strong>and</strong> partners with<strong>in</strong> <strong>and</strong> beyond<strong>the</strong> health sector;• <strong>in</strong>frastructure;• exist<strong>in</strong>g public health <strong>in</strong>tervention <strong>and</strong> o<strong>the</strong>rnon-health-related resources.5.3 Develop <strong>and</strong> implement comprehensive <strong>in</strong>terventionpackages <strong>for</strong> <strong>the</strong> target populations which:• are <strong>in</strong>novative, evidence-based <strong>and</strong> costeffective(e.g. impregnated hammock nets,st<strong>and</strong>by treatment, impregnated blankets,new approaches to surveillance);• <strong>in</strong>clude appropriate delivery systems(e.g. community outreach);• <strong>in</strong>clude appropriate community empowerment<strong>and</strong> mobilization <strong>and</strong> <strong>in</strong><strong>for</strong>mation,education <strong>and</strong> communication materials<strong>and</strong>/or behaviour change communication;• are gender sensitive;• <strong>in</strong>clude appropriate tra<strong>in</strong><strong>in</strong>g models target<strong>in</strong>gcommunities <strong>and</strong> health care providers.50


ActivitiesResponsibleObjective 5: Ensure comprehensive coverage of vulnerable, poor <strong>and</strong>/or marg<strong>in</strong>alized populations at high risk of malariawith appropriate malaria control measures.5.4 Develop <strong>in</strong>tegrated service delivery wherepossible, build<strong>in</strong>g on exist<strong>in</strong>g <strong>in</strong>itiatives whereappropriate, to <strong>in</strong>crease coverage of vulnerablepopulations at different levels(e.g. <strong>for</strong> pregnant women <strong>and</strong> small childrenthrough Integrated Management of ChildhoodIllnesses, maternal <strong>and</strong> child health <strong>and</strong>/or antenatalcare cl<strong>in</strong>ics; <strong>for</strong> HIV-positive persons through voluntarycounsel<strong>in</strong>g <strong>and</strong> test<strong>in</strong>g <strong>and</strong> antiretroviral treatmentcentres; outreach).5.4.1 Introduce <strong>in</strong>termittent preventive treatment <strong>for</strong>pregnant women (IPTp) liv<strong>in</strong>g <strong>in</strong> high transmissionareas <strong>in</strong> antenatal care facilities.5.4 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme, o<strong>the</strong>r health programmes (e.g. Exp<strong>and</strong>edProgramme on Immunization, Mo<strong>the</strong>r <strong>and</strong> Child HealthProgramme, Integrated Management of ChildhoodIllnesses), o<strong>the</strong>r sectors <strong>and</strong> partners.5.4.1 Mo<strong>the</strong>r <strong>and</strong> Child Health Programme, <strong>in</strong> cooperationwith National <strong>Malaria</strong> <strong>Control</strong> Programme.5.5 Establish a focal po<strong>in</strong>t <strong>in</strong> <strong>the</strong> National <strong>Malaria</strong><strong>Control</strong> Programme to manage activities <strong>in</strong> 5.3<strong>and</strong> 5.4 <strong>and</strong> coord<strong>in</strong>ate capacity development.5.6 Monitor <strong>in</strong>tervention success by disaggregat<strong>in</strong>grelevant data by vulnerable group.5.7 Raise <strong>the</strong> profile of <strong>the</strong>se groups <strong>and</strong>mobilize resources.5.5 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme.5.6 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme, health <strong>in</strong><strong>for</strong>mation systems unit.5.7 Governments, M<strong>in</strong>istry of Health, partners <strong>in</strong>clud<strong>in</strong>gWorld Health Organization.5.7.1 Support advocacy <strong>for</strong> <strong>in</strong>ter-programmatic <strong>and</strong><strong>in</strong>tersectoral cooperation through groups <strong>in</strong>clud<strong>in</strong>gAsia-Pacific Economic Cooperation (APEC) <strong>and</strong>Association of Sou<strong>the</strong>ast Asian Nations (ASEAN)(e.g. through <strong>in</strong>tersectoral task <strong>for</strong>ces).5.7.2 Implement advocacy campaigns promot<strong>in</strong>g<strong>in</strong>ter-programmatic <strong>and</strong> <strong>in</strong>tersectoral cooperation.5.7.3 Mobilize resources from <strong>the</strong> Asian Development Bank,World Bank, bilateral donors, Global Fund to FightAIDS, Tuberculosis <strong>and</strong> <strong>Malaria</strong>, private sector <strong>and</strong>o<strong>the</strong>rs.5.7.4 Stimulate <strong>the</strong> development of mean<strong>in</strong>gfulpublic–private partnerships.51


ActivitiesResponsibleObjective 5: Ensure comprehensive coverage of vulnerable, poor <strong>and</strong>/or marg<strong>in</strong>alized populations at high risk of malariawith appropriate malaria control measures.5.8 Conduct relevant operational research toaddress issues.5.8.1 Map vulnerable populations, <strong>and</strong> map malaria burden<strong>in</strong> vulnerable populations.5.8 Research organizations, National <strong>Malaria</strong> <strong>Control</strong>Programme <strong>and</strong> partners, <strong>in</strong>clud<strong>in</strong>g World HealthOrganization.5.8.2 Def<strong>in</strong>e barriers to access.5.8.3 Conduct <strong>in</strong>tervention research on malaria controlstrategies <strong>for</strong> different categories of mobile <strong>and</strong>/or migrant populations, <strong>in</strong>clud<strong>in</strong>g feasibility <strong>and</strong> useof st<strong>and</strong>by treatment.5.8.4 Assess delivery of malaria control to vulnerablepopulations <strong>in</strong> decentralized systems.5.8.5 Explore strategies <strong>for</strong> controll<strong>in</strong>g malaria at<strong>in</strong>ternational borders.5.8.6 Conduct economic analysis of requirements toadequately address vulnerable populations.5.8.7 Assess <strong>the</strong> use of chemoprophylaxis to preventmalaria <strong>in</strong> pregnancy <strong>in</strong> low to moderatetransmission areas.5.8.8 Assess <strong>the</strong> effectiveness of rout<strong>in</strong>e screen<strong>in</strong>g ofpregnant women <strong>for</strong> malaria <strong>in</strong> low to moderatetransmission areas.5.8.9 Cont<strong>in</strong>ue to evaluate <strong>the</strong> effectiveness of <strong>in</strong>termittentpreventive treatment <strong>for</strong> pregnant women(IPTp), <strong>in</strong>clud<strong>in</strong>g <strong>for</strong> P. vivax, <strong>in</strong> areas of moderate tohigh malaria endemicity.52


ActivitiesResponsibleObjective 6: Establish <strong>and</strong>/or streng<strong>the</strong>n <strong>the</strong> rout<strong>in</strong>e malaria surveillance system (all malaria species) <strong>and</strong> ensureadequate outbreak response capability.6.1 F<strong>in</strong>alize biregional guidel<strong>in</strong>es on malariasurveillance (specific to programme stage)<strong>and</strong> outbreak preparedness <strong>and</strong> response(WHO South-East Asia <strong>and</strong> Western Pacific Regions).6.1 World Health Organization withstakeholders <strong>and</strong> partners.6.1.1 Identify essential components of country malariasurveillance (<strong>in</strong>corporat<strong>in</strong>g gender <strong>and</strong> age) <strong>and</strong>outbreak preparedness <strong>and</strong> response systems.6.1.2 Draft guidel<strong>in</strong>es on malaria surveillance <strong>and</strong> malariaoutbreak preparedness <strong>and</strong> response.6.1.3 Harmonize guidel<strong>in</strong>es with those of o<strong>the</strong>r diseasesystems where possible (Communicable DiseaseSurveillance <strong>and</strong> Response, Exp<strong>and</strong>ed Programmeon Immunization, dengue, etc.).6.1.4 Hold consensus workshop, <strong>the</strong>n f<strong>in</strong>alize guidel<strong>in</strong>es<strong>and</strong> dissem<strong>in</strong>ate.6.1.5 Develop tra<strong>in</strong><strong>in</strong>g module.6.2 Facilitate country ownership of malariasurveilance systems <strong>and</strong> outbreak preparedness<strong>and</strong> response guidel<strong>in</strong>es.6.2 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme <strong>and</strong> partners.6.2.1 Establish <strong>and</strong> support technical work<strong>in</strong>g group to adaptmalaria surveillance <strong>and</strong> outbreak preparedness <strong>and</strong>response guidel<strong>in</strong>es to fit national context.6.2.2 Draft, endorse <strong>and</strong> f<strong>in</strong>alize national malaria surveillance<strong>and</strong> outbreak preparedness <strong>and</strong> response guidel<strong>in</strong>es.6.2.3 Explore opportunities to <strong>in</strong>tegrate malaria surveillance<strong>in</strong>to <strong>the</strong> overall health <strong>in</strong><strong>for</strong>mation system.6.3 Streng<strong>the</strong>n national capacity <strong>and</strong> implementmalaria surveillance <strong>and</strong> outbreak preparedness<strong>and</strong> response strategies.6.3 M<strong>in</strong>istry of Health, National <strong>Malaria</strong> <strong>Control</strong>Programme <strong>and</strong> partners.6.3.1 Streng<strong>the</strong>n national capacity to achieve datamanagement requirements (e.g. malaria caseregister, case <strong>in</strong>vestigation <strong>for</strong>m, laboratory register,national malaria database).6.3.2 Draft <strong>and</strong> f<strong>in</strong>alize malaria surveillance <strong>and</strong> outbreakpreparedness <strong>and</strong> response tra<strong>in</strong><strong>in</strong>g modules(based on World Health Organization <strong>and</strong>ACT<strong>Malaria</strong> prototypes).6.3.3 Conduct tra<strong>in</strong><strong>in</strong>g of tra<strong>in</strong>ers.6.3.4 Tra<strong>in</strong> national <strong>and</strong> sub-national staff on malariasurveillance <strong>and</strong> outbreak preparedness <strong>and</strong> response.6.3.5 Ensure adequate staff <strong>and</strong> technical assistance tosupport implementation of malaria surveillance <strong>and</strong> outbreak preparedness <strong>and</strong> response (<strong>in</strong>clud<strong>in</strong>g <strong>in</strong><strong>for</strong>mationtechnology support <strong>for</strong> national malaria database).53


ActivitiesResponsibleObjective 6: Establish <strong>and</strong>/or streng<strong>the</strong>n <strong>the</strong> rout<strong>in</strong>e malaria surveillance system (all malaria species) <strong>and</strong> ensureadequate outbreak response capability.6.4 Monitor <strong>and</strong> report on progress of implement<strong>in</strong>g<strong>the</strong> activities described <strong>in</strong> <strong>the</strong> guidel<strong>in</strong>es.6.5 Develop <strong>and</strong> regularly update national malariarisk stratification <strong>and</strong> estimates of <strong>the</strong>population at risk.6.4 National <strong>Malaria</strong> <strong>Control</strong> Programme.6.5 National <strong>Malaria</strong> <strong>Control</strong> Programme with World HealthOrganization <strong>and</strong> partner support.6.6 Periodically monitor antimalarial drug efficacy<strong>in</strong>clud<strong>in</strong>g P. vivax <strong>in</strong> strategic sent<strong>in</strong>el sites.6.6.1 Streng<strong>the</strong>n capacity <strong>for</strong> <strong>in</strong>-country antimalarial drugefficacy monitor<strong>in</strong>g, follow<strong>in</strong>g <strong>the</strong> World HealthOrganization st<strong>and</strong>ard protocol, <strong>in</strong>clud<strong>in</strong>gmolecular markers.6.6.2 Conduct monitor<strong>in</strong>g.6.6.3 Advocate <strong>for</strong> cont<strong>in</strong>ued support to regional<strong>and</strong> subregional surveillance activities.6.7 Systematically monitor <strong>in</strong>secticide resistance<strong>and</strong> bionomics of malaria vectors.6.8 Effectively share malaria surveillance<strong>in</strong><strong>for</strong>mation among Member States (especiallyacross borders between adm<strong>in</strong>istrative units).6.6.1 National <strong>Malaria</strong> <strong>Control</strong> Programme with World HealthOrganization <strong>and</strong> partner support.6.6.2 National <strong>Malaria</strong> <strong>Control</strong> Programme.6.6.3 World Health Organization, partners.6.7 National <strong>Malaria</strong> <strong>Control</strong> Programme with partner support<strong>in</strong>clud<strong>in</strong>g World Health Organization, ACT<strong>Malaria</strong>.6.8 National <strong>Malaria</strong> <strong>Control</strong> Programme, World HealthOrganization.54


ActivitiesResponsibleObjective 7: Accelerate malaria (all species) elim<strong>in</strong>ation ef<strong>for</strong>ts <strong>in</strong> participat<strong>in</strong>g countries.7.1 Adapt global malaria elim<strong>in</strong>ation guidel<strong>in</strong>es <strong>for</strong><strong>the</strong> Asia Pacific Region <strong>and</strong> develop appropriatest<strong>and</strong>ard operat<strong>in</strong>g procedures (biregional – WHOSouth-East Asia <strong>and</strong> Western Pacific Regions).7.2 Countries committed to malaria elim<strong>in</strong>ation<strong>in</strong> <strong>the</strong> Region adopt modified biregional guidel<strong>in</strong>es.7.1 World Health Organization <strong>and</strong> Asia-Pacific <strong>Malaria</strong><strong>Elim<strong>in</strong>ation</strong> Network, o<strong>the</strong>r stakeholders <strong>and</strong> partners.7.2 National <strong>Malaria</strong> Programme, with support of WorldHealth Organization <strong>and</strong> partners.7.2.1 Align national malaria elim<strong>in</strong>ation strategies withbiregional guidel<strong>in</strong>es (once <strong>the</strong>se become available).7.2.2 Ensure adequate technical support to adjust <strong>and</strong>/orimplement <strong>the</strong> national strategy <strong>for</strong> malaria elim<strong>in</strong>ation.7.3 Implement progressive elim<strong>in</strong>ation of malariafrom selected geographical areas.7.3 National <strong>Malaria</strong> Programme with partner support.7.3.1 Re-orient <strong>the</strong> malaria programme.7.3.2 Familiarize public sector, private sector <strong>and</strong> o<strong>the</strong>rstakeholders with elim<strong>in</strong>ation strategy <strong>and</strong>associated roles <strong>and</strong> responsibilities.7.3.3 Mobilize <strong>and</strong> susta<strong>in</strong> community support, participation<strong>and</strong> resources.7.3.4 Establish fast, effective communication systems <strong>for</strong>health workers at all levels.7.3.5 Establish <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong> monthly collection of malariadata from all private sector health care providers.7.3.6 Establish a geographical <strong>in</strong><strong>for</strong>mation system <strong>for</strong>plann<strong>in</strong>g <strong>and</strong> monitor<strong>in</strong>g progress <strong>in</strong> elim<strong>in</strong>ation.7.3.7 Implement comprehensive <strong>in</strong>vestigation <strong>for</strong> allcases identified through rout<strong>in</strong>e passive case detection<strong>and</strong> follow-up.7.3.8 Conduct prompt <strong>in</strong>-depth <strong>in</strong>vestigations <strong>in</strong> allsuspected transmission foci accord<strong>in</strong>g toelim<strong>in</strong>ation guidel<strong>in</strong>es.7.3.9 Provide timely <strong>and</strong> effective focal <strong>in</strong>door residualspray<strong>in</strong>g accord<strong>in</strong>g to st<strong>and</strong>ard operat<strong>in</strong>g procedures.7.3.10 Ensure radical treatment <strong>for</strong> all P. vivax cases identified,<strong>and</strong> gametocyte treatment <strong>for</strong> P. falciparum cases.55


ActivitiesResponsibleObjective 7: Accelerate malaria (all species) elim<strong>in</strong>ation ef<strong>for</strong>ts <strong>in</strong> participat<strong>in</strong>g countries.7.4 Ensure strong technical cooperation withcountries, relevant networks <strong>and</strong> research<strong>in</strong>stitutions committed to malaria elim<strong>in</strong>ation.7.4 World Health Organization with stakeholders<strong>and</strong> partners.7.4.1 Formulate <strong>and</strong> coord<strong>in</strong>ate an elim<strong>in</strong>ation researchagenda (with special attention to P. vivax).7.4.2 Provide necessary technical support.7.4.3 Dissem<strong>in</strong>ate annual progress <strong>and</strong> technical reports.7.4.4 Encourage <strong>and</strong> support <strong>the</strong> development <strong>and</strong> fund<strong>in</strong>gof cross-border elim<strong>in</strong>ation operations.7.5 Monitor progress to malaria elim<strong>in</strong>ation.7.5.1 Establish a national malaria elim<strong>in</strong>ation monitor<strong>in</strong>gcommittee to monitor progress.7.5 National <strong>Malaria</strong> Program with World HealthOrganization, Asia-Pacific <strong>Malaria</strong> <strong>Elim<strong>in</strong>ation</strong> Network<strong>and</strong> o<strong>the</strong>r partners.7.5.2 Conduct jo<strong>in</strong>t plann<strong>in</strong>g <strong>and</strong> monitor<strong>in</strong>g withWHO Western Pacific <strong>and</strong> South-East Asia <strong>Regional</strong>Offices, Asia-Pacific <strong>Malaria</strong> <strong>Elim<strong>in</strong>ation</strong> Network<strong>and</strong> experts from countries which are implement<strong>in</strong>gelim<strong>in</strong>ation.7.5.3 Support <strong>in</strong>tercountry malaria elim<strong>in</strong>ation meet<strong>in</strong>gs.56


ActivitiesResponsibleObjective 7: Accelerate malaria (all species) elim<strong>in</strong>ation ef<strong>for</strong>ts <strong>in</strong> participat<strong>in</strong>g countries.7.6 Conta<strong>in</strong> <strong>and</strong> ultimately elim<strong>in</strong>ate artemis<strong>in</strong><strong>in</strong>resistantmalaria parasites (P. falciparum)<strong>in</strong> affected areas.7.6 National <strong>Malaria</strong> Programme <strong>in</strong> conta<strong>in</strong>ment area,World Health Organization with stakeholders<strong>and</strong> partners.7.6.1 Elim<strong>in</strong>ate artemis<strong>in</strong><strong>in</strong>-resistant parasites bydetect<strong>in</strong>g all malaria cases <strong>in</strong> target areas <strong>and</strong>ensur<strong>in</strong>g effective treatment <strong>and</strong> gametocyte clearance.7.6.2 Decrease drug pressure <strong>for</strong> selection ofartemis<strong>in</strong><strong>in</strong> resistant malaria parasites.7.6.3 Prevent transmission of artemis<strong>in</strong><strong>in</strong>-resistantmalaria parasites by high coverage mosquito control<strong>and</strong> personal protection ef<strong>for</strong>ts.7.6.4 Limit <strong>the</strong> spread of artemis<strong>in</strong><strong>in</strong>-resistant malariaparasites by effectively target<strong>in</strong>g mobile <strong>and</strong>/ormigrant populations.7.6.5 Support conta<strong>in</strong>ment <strong>and</strong>/or elim<strong>in</strong>ation of artemis<strong>in</strong><strong>in</strong>resistantparasites through comprehensive behaviourchange communication, community mobilization<strong>and</strong> advocacy.7.6.6 Undertake basic <strong>and</strong> operational research to fillknowledge gaps <strong>and</strong> ensure that conta<strong>in</strong>ment <strong>and</strong>/or elim<strong>in</strong>ation strategies applied are evidence-based.7.6.7 Provide effective management <strong>and</strong> coord<strong>in</strong>ation toenable rapid <strong>and</strong> high-quality implementation of <strong>the</strong>conta<strong>in</strong>ment <strong>and</strong>/or elim<strong>in</strong>ation strategy.7.6.8 Explore mechanisms that would trigger <strong>in</strong>ternationalreport<strong>in</strong>g under <strong>the</strong> International Health Regulations(IHR) <strong>in</strong> <strong>the</strong> context of artemis<strong>in</strong><strong>in</strong> resistance.7.7 Conduct operational research to supportelim<strong>in</strong>ation ef<strong>for</strong>ts as appropriate.7.7 Research organizations, National <strong>Malaria</strong> Programme,partners, World Health Organization.7.7.1 Develop, assess <strong>and</strong>/or adapt feasible highlysensitive diagnostic tests <strong>for</strong> mass screen<strong>in</strong>g.7.7.2 Conduct economic analysis of targeted elim<strong>in</strong>ationover <strong>the</strong> medium-term.7.7.3 Conduct operational research aimed at develop<strong>in</strong>ga strategy <strong>for</strong> <strong>the</strong> elim<strong>in</strong>ation of zoonoticPlasmodium knowlesi.57


WHO Western Pacific RegionPUBLICATIONISBN-13 978 92 9061 557 6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!